Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Crohns Colitis

Retrieve available abstracts of 542 articles:
HTML format



Single Articles


    June 2022
  1. ILVEMARK JFKF, Wilkens R, Thielsen P, Dige A, et al
    Early intestinal ultrasound predicts intravenous corticosteroid response in hospitalized patients with severe ulcerative colitis.
    J Crohns Colitis. 2022 Jun 13. pii: 6607631. doi: 10.1093.
    PubMed     Abstract available


  2. KIM KO, Kim EY, Lee YJ, Lee HS, et al
    Efficacy, safety and tolerability of oral sulfate tablet for bowel preparation in patients with inflammatory bowel disease: Multicenter randomized controlled study.
    J Crohns Colitis. 2022 Jun 11. pii: 6605993. doi: 10.1093.
    PubMed     Abstract available


  3. JAGT JZ, Verburgt CM, de Vries R, de Boer NKH, et al
    Faecal metabolomics in paediatric inflammatory bowel disease: a systematic review.
    J Crohns Colitis. 2022 Jun 9. pii: 6605030. doi: 10.1093.
    PubMed     Abstract available


  4. CLARKSTON K, Karns R, Jegga AG, Sharma M, et al
    Targeted Assessment of Mucosal Immune Gene Expression Predicts Clinical Outcomes in Children with Ulcerative Colitis.
    J Crohns Colitis. 2022 Jun 4. pii: 6602063. doi: 10.1093.
    PubMed     Abstract available


    May 2022
  5. TORRENTE F, Meade S, Benchimol EI, de Ridder L, et al
    Thromboprophylaxis use in paediatric inflammatory bowel disease: an international RAND appropriateness panel.
    J Crohns Colitis. 2022 May 24. pii: 6591364. doi: 10.1093.
    PubMed     Abstract available


  6. DANESE S, Peyrin-Biroulet L
    Evolution of IL-23 Blockade in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16.
    PubMed    


  7. SEWELL GW, Kaser A
    Interleukin-23 in the Pathogenesis of Inflammatory Bowel Disease and Implications for Therapeutic Intervention.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  8. PARIGI TL, Iacucci M, Ghosh S
    Blockade of IL-23: What is in the Pipeline?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  9. D'AMICO F, Peyrin-Biroulet L, Danese S
    Ustekinumab in Crohn's Disease: New Data for Positioning in Treatment Algorithm.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  10. MCDONALD BD, Dyer EC, Rubin DT
    IL-23 Monoclonal Antibodies for IBD: So Many, So Different?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  11. VALENTI M, Narcisi A, Pavia G, Gargiulo L, et al
    What Can IBD Specialists Learn from IL-23 Trials in Dermatology?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  12. ATREYA R, Neurath MF
    IL-23 Blockade in Anti-TNF Refractory IBD: From Mechanisms to Clinical Reality.
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  13. GOTTLIEB ZS, Sands BE
    Personalised Medicine with IL-23 Blockers: Myth or Reality?
    J Crohns Colitis. 2022;16.
    PubMed     Abstract available


  14. CALVET X, Panes J, Gallardo-Escudero J, de la Cuadra-Grande A, et al
    Multicriteria Decision Analysis for Updating of Quality Indicators for Inflammatory Bowel Disease Comprehensive Care Units in Spain.
    J Crohns Colitis. 2022 May 11. pii: 6584605. doi: 10.1093.
    PubMed     Abstract available


  15. ROGLER G
    No Need to Scope? Monitoring of Treatment Response in IBD Patients by Transabdominal Ultrasound.
    J Crohns Colitis. 2022;16:521-522.
    PubMed    


  16. KAKUTA Y, Iwaki H, Umeno J, Kawai Y, et al
    Crohn's Disease and Early Exposure to Thiopurines are Independent Risk Factors for Mosaic Chromosomal Alterations in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2022;16:643-655.
    PubMed     Abstract available


  17. VERBURGT CM, Dunn KA, Van Limbergen JE
    Dietary Therapy Reduces Pro-inflammatory Microbiome Features in Paediatric Crohn's Disease.
    J Crohns Colitis. 2022;16:682-684.
    PubMed    


  18. NARULA N, Wong ECL, Colombel JF, Sandborn WJ, et al
    Early Reduction in MM-SES-CD Score After Initiation of Biologic Therapy is Highly Specific for 1-year Endoscopic Remission in Moderate to Severe Crohn's Disease.
    J Crohns Colitis. 2022;16:616-624.
    PubMed     Abstract available


  19. BOTS S, De Voogd F, De Jong M, Ligtvoet V, et al
    Point-of-care Intestinal Ultrasound in IBD Patients: Disease Management and Diagnostic Yield in a Real-world Cohort and Proposal of a Point-of-care Algorithm.
    J Crohns Colitis. 2022;16:606-615.
    PubMed     Abstract available


  20. DAOUD ND, Hashash JG, Picco MF, Farraye FA, et al
    Faecal Calprotectin from Ileostomy Output Is Sensitive and Specific for the Prediction of Small Bowel Inflammation in Patients with Crohn's Disease.
    J Crohns Colitis. 2022;16:601-605.
    PubMed     Abstract available


  21. KUCHARZIK T, Tielbeek J, Carter D, Taylor SA, et al
    ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16:523-543.
    PubMed     Abstract available


  22. SUN TY, Li YQ, Zhao FQ, Sun HM, et al
    MiR-1-3p and MiR-124-3p Synergistically Damage the Intestinal Barrier in the Ageing Colon.
    J Crohns Colitis. 2022;16:656-667.
    PubMed     Abstract available


  23. ALSOUD D, De Hertogh G, Compernolle G, Tops S, et al
    Real-world endoscopic and histologic outcomes are correlated with ustekinumab exposure in patients with ulcerative colitis.
    J Crohns Colitis. 2022 May 9. pii: 6582859. doi: 10.1093.
    PubMed     Abstract available


  24. STODTMANN S, Chen MJ, Siovitz L, Bereswill M, et al
    Bridging Fixed Dose to Body Weight-Based Regimen of Adalimumab in Pediatric Ulcerative Colitis Using a Pharmacometric Modeling Approach: Case Study with the Phase 3 ENVISION I Trial.
    J Crohns Colitis. 2022 May 8. pii: 6582407. doi: 10.1093.
    PubMed     Abstract available


  25. SHRESTHA S, Brand JS, Jaras J, Schoultz I, et al
    Association between inflammatory bowel disease and spondyloarthritis: findings from a nationwide study in Sweden.
    J Crohns Colitis. 2022 May 5. pii: 6581445. doi: 10.1093.
    PubMed     Abstract available


  26. WONG C, van Oostrom J, Bossuyt P, Pittet V, et al
    A narrative systematic review and categorisation of outcomes in Inflammatory Bowel Disease to inform a Core Outcome Set for real-world evidence.
    J Crohns Colitis. 2022 May 5. pii: 6580715. doi: 10.1093.
    PubMed     Abstract available


  27. POULLENOT F, Amiot A, Nachury M, Viennot S, et al
    Comparative risk of incident cancer in patients with Inflammatory Bowel Disease with prior non-digestive malignancy according to immunomodulator: a multicenter cohort study.
    J Crohns Colitis. 2022 May 5. pii: 6580681. doi: 10.1093.
    PubMed     Abstract available


    April 2022
  28. DE GALAN C, Truyens M, Peeters H, Mesonero Gismero F, et al
    The impact of vedolizumab and ustekinumab on articular extra-intestinal manifestations in inflammatory bowel disease patients: a real-life multicentric cohort study.
    J Crohns Colitis. 2022 Apr 20. pii: 6571450. doi: 10.1093.
    PubMed     Abstract available


  29. FERNANDEZ ME, Nazar FN, Moine LB, Jaime CE, et al
    Network analysis of inflammatory bowel disease research: towards the interactome.
    J Crohns Colitis. 2022 Apr 19. pii: 6570854. doi: 10.1093.
    PubMed     Abstract available


  30. UNGARO RC, Chou B, Mo J, Ursos L, et al
    Impact of COVID-19 on Healthcare Resource Utilization among Patients with Inflammatory Bowel Disease in the USA.
    J Crohns Colitis. 2022 Apr 9. pii: 6565722. doi: 10.1093.
    PubMed     Abstract available


  31. DONG C, Chan SSM, Jantchou P, Racine A, et al
    Meat intake is associated with a higher risk of ulcerative colitis in a large European prospective cohort study.
    J Crohns Colitis. 2022 Apr 9. pii: 6565743. doi: 10.1093.
    PubMed     Abstract available


  32. DOLINGER MT, Rolfes P, Spencer E, Stoffels G, et al
    Outcomes of Children With Inflammatory Bowel Disease Who Develop Anti-Tumor Necrosis Factor Induced Skin Reactions.
    J Crohns Colitis. 2022 Apr 7. pii: 6564796. doi: 10.1093.
    PubMed     Abstract available


  33. HARDY PY, Fikri J, Libbrecht D, Louis E, et al
    Pain characteristics in patients with inflammatory bowel disease: A monocentric cross-sectional study.
    J Crohns Colitis. 2022 Apr 4. pii: 6563361. doi: 10.1093.
    PubMed     Abstract available


  34. CHAPARRO M, Kunovsky L, Aguas M, Livne M, et al
    Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study).
    J Crohns Colitis. 2022 Apr 4. pii: 6563346. doi: 10.1093.
    PubMed     Abstract available


  35. COLLEN LV, Kim DY, Field M, Okoroafor I, et al
    Clinical Phenotypes and Outcomes in Monogenic versus Non-Monogenic Very Early Onset Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Apr 2. pii: 6562761. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  36. CERNA K, Duricova D, Hindos M, Hindos HJ, et al
    Cellular and humoral immune responses to SARS-CoV-2 vaccination in inflammatory bowel disease patients.
    J Crohns Colitis. 2022 Mar 31. pii: 6561818. doi: 10.1093.
    PubMed     Abstract available


  37. KHAN N, Trivedi C, Aberra F, Pernes T, et al
    Safety of Recombinant Zoster Vaccine in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 29. pii: 6555677. doi: 10.1093.
    PubMed     Abstract available


  38. DING NS, Tassone D, Al-Bakir I, Wu K, et al
    Systematic review: The impact and importance of body composition in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 24. pii: 6553364. doi: 10.1093.
    PubMed     Abstract available


  39. MORTENSEN JH, Sinkeviciute D, Manon-Jensen T, Domislovic V, et al
    A specific calprotectin neo-epitope (CPa9-HNE) in serum from inflammatory bowel disease patients is associated with neutrophil activity and endoscopic severity.
    J Crohns Colitis. 2022 Mar 19. pii: 6550845. doi: 10.1093.
    PubMed     Abstract available


  40. HYAMS JS, Turner D, Cohen SA, Szakos E, et al
    Pharmacokinetics, Safety, and Efficacy of Intravenous Vedolizumab in Paediatric Patients with Ulcerative Colitis or Crohn's Disease: Results from the Phase 2 HUBBLE Study.
    J Crohns Colitis. 2022 Mar 17. pii: 6550285. doi: 10.1093.
    PubMed     Abstract available


  41. VELOSA M, Hochner H, Yerushalmi B, Harel S, et al
    Pre and perinatal factors predicting Inflammatory Bowel Disease - a population-based study with fifty years follow-up.
    J Crohns Colitis. 2022 Mar 17. pii: 6550290. doi: 10.1093.
    PubMed     Abstract available


  42. SANDBORN WJ, Lewis JD, Panes J, Loftus EV, et al
    Association Between Proposed Definitions of Clinical Remission/Response and Well-Being in Patients With Crohn's Disease.
    J Crohns Colitis. 2022;16:444-451.
    PubMed     Abstract available


  43. SUAU R, Pardina E, Domenech E, Loren V, et al
    The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn's Disease.
    J Crohns Colitis. 2022;16:472-489.
    PubMed     Abstract available


  44. BLE A, Renzulli C, Cenci F, Grimaldi M, et al
    The Relationship Between Endoscopic and Clinical Recurrence in Postoperative Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2022;16:490-499.
    PubMed     Abstract available


  45. PHILLIPS F, Verstockt B, Sladek M, de Boer N, et al
    Orofacial Granulomatosis Associated with Crohn's Disease: a Multicentre Case Series.
    J Crohns Colitis. 2022;16:430-435.
    PubMed     Abstract available


  46. NGUYEN NH, Picetti D, Dulai PS, Jairath V, et al
    Machine Learning-based Prediction Models for Diagnosis and Prognosis in Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2022;16:398-413.
    PubMed     Abstract available


  47. VIEUJEAN S, Loly JP, Boutaffala L, Meunier P, et al
    Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: A Phase I-II Clinical Study.
    J Crohns Colitis. 2022;16:506-510.
    PubMed     Abstract available


  48. CHANCHLANI N, Lin S, Chee D, Hamilton B, et al
    Adalimumab and Infliximab Impair SARS-CoV-2 Antibody Responses: Results from a Therapeutic Drug Monitoring Study in 11 422 Biologic-Treated Patients.
    J Crohns Colitis. 2022;16:389-397.
    PubMed     Abstract available


  49. LEVER G, Chipeta H, Glanville T, Selinger C, et al
    Perineal Outcomes After Delivery in 179 Mothers with Inflammatory Bowel Disease Compared to 31 258 Controls: A Single-Centre Cohort Study.
    J Crohns Colitis. 2022;16:511-514.
    PubMed     Abstract available


  50. FEAKINS R, Torres J, Borralho-Nunes P, Burisch J, et al
    ECCO Topical Review on Clinicopathological Spectrum and Differential Diagnosis of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022;16:343-368.
    PubMed     Abstract available


  51. ROBERTSON AR, Webster KL
    Disease activity in the final years of life for patients with longstanding Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Mar 7. pii: 6543872. doi: 10.1093.
    PubMed    


  52. ABREU MT, Rowbotham DS, Danese S, Sandborn WJ, et al
    Efficacy and Safety of Maintenance Ustekinumab for Ulcerative Colitis Through 3 Years: UNIFI Long-term Extension.
    J Crohns Colitis. 2022 Mar 3. pii: 6542054. doi: 10.1093.
    PubMed     Abstract available


  53. SCIBERRAS M, Karmiris K, Nascimento C, Tabone T, et al
    Mental health, work presenteeism and exercise in inflammatory bowel disease.
    J Crohns Colitis. 2022 Mar 3. pii: 6542057. doi: 10.1093.
    PubMed     Abstract available


  54. BURGESS CJ, Schnier C, Wood R, Henderson P, et al
    Prematurity, delivery method and infant feeding type are not associated with paediatric-onset inflammatory bowel disease risk: A Scottish retrospective birth cohort study.
    J Crohns Colitis. 2022 Mar 1. pii: 6540489. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  55. COTTRON C, Treton X, Altwegg R, Reenaers C, et al
    How to manage inflammatory bowel disease patients when they withdraw anti-TNF due to severe anti-TNF-induced skin lesions? A multicenter cohort study.
    J Crohns Colitis. 2022 Feb 26. pii: 6537448. doi: 10.1093.
    PubMed     Abstract available


  56. NOWAK JK, Adams AT, Kalla R, Lindstrom JC, et al
    Characterization of the circulating transcriptomic landscape in inflammatory bowel disease provides evidence for dysregulation of multiple transcription factors including NFE2, SPI1, CEBPB, and IRF2.
    J Crohns Colitis. 2022 Feb 25. pii: 6536718. doi: 10.1093.
    PubMed     Abstract available


  57. TRACY M, Khalili H
    You Are What You Eat? Growing Evidence That Diet Influences the Risk of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Feb 23. pii: 6534662. doi: 10.1093.
    PubMed    


  58. BISLENGHI G, Sucameli F, Fieuws S, Ferrante M, et al
    Non-conventional Versus Conventional Strictureplasties for Crohn's Disease. A Systematic Review and Meta-analysis of Treatment Outcomes.
    J Crohns Colitis. 2022;16:319-330.
    PubMed     Abstract available


  59. DHALIWAL J, Carroll MW, deBruyn JC, Ricciuto A, et al
    The Phenotypic Spectrum of New-onset IBD in Canadian Children of South Asian Ethnicity: A Prospective Multi-Centre Comparative Study.
    J Crohns Colitis. 2022;16:216-223.
    PubMed     Abstract available


  60. CLEMENT F, Nougarede A, Combe S, Kermarrec F, et al
    Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2022;16:286-300.
    PubMed     Abstract available


  61. ELDRIDGE F, Raine T
    Understanding and Addressing the Psychological Burden of IBD.
    J Crohns Colitis. 2022;16:177-178.
    PubMed    


  62. LAUDISI F, Stolfi C, Bevivino G, Maresca C, et al
    GATA6 Deficiency Leads to Epithelial Barrier Dysfunction and Enhances Susceptibility to Gut Inflammation.
    J Crohns Colitis. 2022;16:301-311.
    PubMed     Abstract available


  63. BACSUR P, Farkas K, Molnar T
    Area of the IBD Disk Correlated Strongly with Disease Activity Compared with the Conventionally Used IBD Disk Score.
    J Crohns Colitis. 2022;16:336.
    PubMed    


  64. OSTROWSKI S, Croft A
    Viral enteric infections in acute severe ulcerative colitis.
    J Crohns Colitis. 2022 Feb 15. pii: 6528523. doi: 10.1093.
    PubMed     Abstract available


  65. CROFT A, Lord A, Radford-Smith G
    Markers of systemic inflammation in acute attacks of ulcerative colitis: What level of C-reactive protein constitutes severe colitis?
    J Crohns Colitis. 2022 Feb 11. pii: 6527048. doi: 10.1093.
    PubMed     Abstract available


  66. MOOKHOEK A, Haasnoot ML, Bredenoord AJ, Ma C, et al
    The clinical significance of eosinophils in ulcerative colitis: a systematic review.
    J Crohns Colitis. 2022 Feb 9. pii: 6524727. doi: 10.1093.
    PubMed     Abstract available


  67. HUA X, Lopes EW, Burke KE, Ananthakrishnan AN, et al
    Smoking behavior changes after diagnosis of inflammatory bowel disease and risk of all-cause mortality.
    J Crohns Colitis. 2022 Feb 1. pii: 6518234. doi: 10.1093.
    PubMed     Abstract available


    January 2022
  68. VERMEIRE S, D'Haens G, Baert F, Danese S, et al
    Efficacy and Safety of Subcutaneous Vedolizumab in Patients With Moderately to Severely Active Crohn's Disease: Results From the VISIBLE 2 Randomised Trial.
    J Crohns Colitis. 2022;16:27-38.
    PubMed     Abstract available


  69. ALBSHESH A, Eder P, Ribaldone DG, Oldenburg B, et al
    Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2022;16:91-97.
    PubMed     Abstract available


  70. ZILBAUER M, Heuschkel R
    Disease Prognostic Biomarkers in Inflammatory Bowel Diseases-A Reality Check.
    J Crohns Colitis. 2022;16:162-165.
    PubMed     Abstract available


  71. FERREIRA JPS, de Mascarenhas Saraiva MJDQEC, Afonso JPL, Ribeiro TFC, et al
    Identification of Ulcers and Erosions by the Novel Pillcam Crohn's Capsule Using a Convolutional Neural Network: A Multicentre Pilot Study.
    J Crohns Colitis. 2022;16:169-172.
    PubMed     Abstract available


  72. HELWIG U, Fischer I, Hammer L, Kolterer S, et al
    Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets?
    J Crohns Colitis. 2022;16:57-67.
    PubMed     Abstract available


  73. KABIR M, Thomas-Gibson S, Hart AL, Wilson A, et al
    Perception of Cancer Risk and Management Practice for Colitis-associated Dysplasia Is Influenced by Colonoscopy Experience and Workplace Affiliation: Results of an International Clinician Survey.
    J Crohns Colitis. 2022;16:39-48.
    PubMed     Abstract available


  74. FULFORTH J, Gearry R
    Inequitable Access to IBD Therapies Extends Beyond Developing Nations.
    J Crohns Colitis. 2022;16:173-174.
    PubMed    


  75. HANZEL J, Jairath V
    A TIGER Among Endoscopic Indices in Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jan 21. pii: 6513472. doi: 10.1093.
    PubMed    


  76. NUNEZ F P, Quera R, Bay C, Castro F, et al
    Drug-induced liver injury used in the treatment of Inflammatory Bowel Disease.
    J Crohns Colitis. 2022 Jan 19. pii: 6511546. doi: 10.1093.
    PubMed     Abstract available


  77. ELLUL P, Reves J, Abreu B, Chaparro M, et al
    Implementation and short-term adverse events of anti-SARS-CoV-2 vaccines in Inflammatory Bowel Disease patients: an international web-based survey.
    J Crohns Colitis. 2022 Jan 17. pii: 6509060. doi: 10.1093.
    PubMed     Abstract available


  78. JUZENAS S, Hubenthal M, Lindqvist CM, Kruse R, et al
    Detailed transcriptional landscape of peripheral blood points to increased neutrophil activation in treatment-naive inflammatory bowel disease.
    J Crohns Colitis. 2022 Jan 11. pii: 6503823. doi: 10.1093.
    PubMed     Abstract available


  79. DE BOER NK, van Lookeren FL, Tack GJ
    The launch of an online national multidisciplinary expert panel for inflammatory bowel disease.
    J Crohns Colitis. 2022 Jan 6. pii: 6499222. doi: 10.1093.
    PubMed    


  80. HERNANDEZ-ROCHA C, Nayeri S, Turpin W, Steel M, et al
    Combined histo-endoscopic remission but not endoscopic healing alone in ulcerative colitis is associated with a mucosal transcriptional profile resembling healthy mucosa.
    J Crohns Colitis. 2022 Jan 6. pii: 6499459. doi: 10.1093.
    PubMed     Abstract available


  81. TORRENTE F, Hansen R
    Venous Thromboembolism in Children with Inflammatory Bowel Disease: When is the Right Time for Thromboprophylaxis?
    J Crohns Colitis. 2022 Jan 3. pii: 6494523. doi: 10.1093.
    PubMed    


    December 2021
  82. VENTRESS E, Young D, Rahmany S, Harris C, et al
    Transitioning from intRavenous to subcutAneous VEdolizumab in patients with infLammatory bowEl diSeaSe (TRAVELESS).
    J Crohns Colitis. 2021 Dec 22. pii: 6478741. doi: 10.1093.
    PubMed     Abstract available


  83. GIANNINI EG, Demarzo MG, Bodini G
    Elevated Adherence to Vaccination Against SARS-CoV-2 Among Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:2142-2143.
    PubMed    


  84. GOLDBERG R, Clough JN, Roberts LB, Sanchez J, et al
    A Crohn's Disease-associated IL2RA Enhancer Variant Determines the Balance of T Cell Immunity by Regulating Responsiveness to IL-2 Signalling.
    J Crohns Colitis. 2021;15:2054-2065.
    PubMed     Abstract available


  85. RYVCHIN R, Dubinsky V, Rabinowitz K, Wasserberg N, et al
    Alteration in Urease-producing Bacteria in the Gut Microbiomes of Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:2066-2077.
    PubMed     Abstract available


  86. SPALINGER MR, Schwarzfischer M, Niechcial A, Atrott K, et al
    Loss of PTPN22 Promotes Intestinal Inflammation by Compromising Granulocyte-mediated Antibacterial Defence.
    J Crohns Colitis. 2021;15:2118-2130.
    PubMed     Abstract available


  87. DERIKX LAAP, Dolby HW, Plevris N, Lucaciu L, et al
    Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naive SB5 Observational Cohorts.
    J Crohns Colitis. 2021;15:2011-2021.
    PubMed     Abstract available


  88. FERRANTE M, Feagan BG, Panes J, Baert F, et al
    Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study.
    J Crohns Colitis. 2021;15:2001-2010.
    PubMed     Abstract available


  89. NI H, Chen Y, Xia W, Wang C, et al
    SATB2 Defect Promotes Colitis and Colitis-associated Colorectal Cancer by Impairing Cl-/HCO3- Exchange and Homeostasis of Gut Microbiota.
    J Crohns Colitis. 2021;15:2088-2102.
    PubMed     Abstract available


  90. WANG L, Zhang N, Han D, Su P, et al
    MTDH Promotes Intestinal Inflammation by Positively Regulating TLR Signalling.
    J Crohns Colitis. 2021;15:2103-2117.
    PubMed     Abstract available


  91. CASADO-BEDMAR M, Viennois E
    microRNA and gut microbiota: Tiny but mighty - Novel insights of their crosstalk in inflammatory bowel disease pathogenesis and therapeutics.
    J Crohns Colitis. 2021 Dec 16. pii: 6464304. doi: 10.1093.
    PubMed     Abstract available


  92. CALAFAT M, Manosa M, Ricart E, Nos P, et al
    Risk of immunomediated adverse events and loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry.
    J Crohns Colitis. 2021 Dec 3. pii: 6448705. doi: 10.1093.
    PubMed     Abstract available


  93. FESTA S, Zerboni G, Derikx LAAP, Ribaldone DG, et al
    Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series.
    J Crohns Colitis. 2021 Dec 1. pii: 6447455. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  94. GORDON IO, Abushamma S, Kurowski JA, Holubar SD, et al
    Pediatric Ulcerative Colitis Is A Fibrotic Disease And Linked With Chronicity Of Inflammation.
    J Crohns Colitis. 2021 Nov 29. pii: 6445941. doi: 10.1093.
    PubMed     Abstract available


  95. BAR-YOSEPH H, Blatt A, Gerassy S, Pressman S, et al
    Differential serum-intestinal dynamics of infliximab and adalimumab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 24. pii: 6438514. doi: 10.1093.
    PubMed     Abstract available


  96. PRENTICE RE, Ross AL, Flanagan EK
    Management of Pregnant Women with Inflammatory Bowel Disease and COVID-19-Balancing Risks of Delayed Treatment Recommencement.
    J Crohns Colitis. 2021 Nov 23. pii: 6433604. doi: 10.1093.
    PubMed    


  97. PAPAEFTHYMIOU A, Potamianos S, Goulas A, Doulberis M, et al
    Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents.
    J Crohns Colitis. 2021 Nov 22. pii: 6433262. doi: 10.1093.
    PubMed     Abstract available


  98. ATIA O, Orlanski-Meyer E, Lujan R, Ledderman N, et al
    Colectomy Rates did not Decrease in Paediatric- and Adult-Onset Ulcerative Colitis During the Biologics Era: A Nationwide Study From the epi-IIRN.
    J Crohns Colitis. 2021 Nov 20. pii: 6432553. doi: 10.1093.
    PubMed     Abstract available


  99. BACSUR P, Farkas K, Molnar T
    Outcome of immediate dose optimization of infliximab in inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Nov 18. pii: 6430840. doi: 10.1093.
    PubMed    


  100. GUPTA R, MacIsaac M, Wright EK
    Sleeve gastrectomy in patients with inflammatory bowel disease is not associated with worsening disease.
    J Crohns Colitis. 2021 Nov 17. pii: 6430439. doi: 10.1093.
    PubMed    


  101. D'AMICO F, Magro F, Peyrin-Biroulet L, Danese S, et al
    Positioning filgotinib in the treatment algorithm of moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Nov 16. pii: 6429427. doi: 10.1093.
    PubMed     Abstract available


  102. NICHOLSON MR, Alexander E, Ballal S, Davidovics Z, et al
    Efficacy and Outcomes of Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection in Children with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Nov 12. pii: 6425925. doi: 10.1093.
    PubMed     Abstract available


  103. VAN ERP LW, Neijenhuis MK, Heida W, Derwig J, et al
    Improving care for recently diagnosed inflammatory bowel disease patients: Lessons learned from a patient-centred, mixed-method study.
    J Crohns Colitis. 2021 Nov 10. pii: 6425110. doi: 10.1093.
    PubMed     Abstract available


  104. CHARPY F, Altwegg R, Debourdeau A
    Disseminated tuberculosis in a patient treated with tofacitinib for ulcerative colitis.
    J Crohns Colitis. 2021 Nov 9. pii: 6424411. doi: 10.1093.
    PubMed    


  105. AGRAWAL M, Zhang X, Brenner EJ, Ungaro RC, et al
    The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry.
    J Crohns Colitis. 2021;15:1877-1884.
    PubMed     Abstract available


  106. WETWITTAYAKHLANG P, Lakatos PL
    Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!
    J Crohns Colitis. 2021;15:1783-1784.
    PubMed    


  107. ROSH JR, Turner D, Griffiths A, Cohen SA, et al
    Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn's Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study.
    J Crohns Colitis. 2021;15:1931-1942.
    PubMed     Abstract available


  108. REZAZADEH ARDABILI A, Goudkade D, Wintjens D, Romberg-Camps M, et al
    Histopathological Features in Colonic Biopsies at Diagnosis Predict Long-term Disease Course in Patients with Crohn's Disease.
    J Crohns Colitis. 2021;15:1885-1897.
    PubMed     Abstract available


  109. SELIN KA, Hedin CRH, Villablanca EJ
    Immunological Networks Defining the Heterogeneity of Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:1959-1973.
    PubMed     Abstract available


  110. NAFTALI T, Bar-Lev Schleider L, Almog S, Meiri D, et al
    Oral CBD-rich Cannabis Induces Clinical but Not Endoscopic Response in Patients with Crohn's Disease, a Randomised Controlled Trial.
    J Crohns Colitis. 2021;15:1799-1806.
    PubMed     Abstract available


  111. LUO J, Xu Z, Noordam R, van Heemst D, et al
    Depression and Inflammatory Bowel Disease: A Bidirectional two-sample Mendelian Randomization Study.
    J Crohns Colitis. 2021 Nov 5. pii: 6421452. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  112. GARRIDO I, Lopes S, Macedo G
    "Safety of COVID-19 vaccination in inflammatory bowel disease patients on biologic therapy".
    J Crohns Colitis. 2021 Oct 30. pii: 6414658. doi: 10.1093.
    PubMed    


  113. LIMA SF, Longman RS
    Eating for Two: Diet and the Microbiome in Ulcerative Colitis.
    J Crohns Colitis. 2021 Oct 27. pii: 6412629. doi: 10.1093.
    PubMed    


  114. FRIEDMAN S, Zegers FD, Jolving LR, Nielsen J, et al
    Postpartum surgical complications in women with inflammatory bowel disease after caesarian section: A Danish nationwide cohort study.
    J Crohns Colitis. 2021 Oct 27. pii: 6412778. doi: 10.1093.
    PubMed     Abstract available


  115. CHARKAOUI M, Hajage D, Tubach F, Laurent B, et al
    Impact of anti-tumor necrosis factor agents on the risk of colorectal cancer in patients with ulcerative colitis: nationwide French cohort study.
    J Crohns Colitis. 2021 Oct 18. pii: 6399096. doi: 10.1093.
    PubMed     Abstract available


  116. RAINE T, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390052. doi: 10.1093.
    PubMed    


  117. SPINELLI A, Bonovas S, Burisch J, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.
    J Crohns Colitis. 2021 Oct 12. pii: 6390023. doi: 10.1093.
    PubMed     Abstract available


  118. ELFIKY AMI, Ghiboub M, Li Yim AYF, Hageman IL, et al
    Carboxylesterase-1 assisted targeting of HDAC inhibitors to mononuclear myeloid cells in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 11. pii: 6387695. doi: 10.1093.
    PubMed     Abstract available


  119. WALENTYNOWICZ M, van de Pavert I, Fierens L, Coenen S, et al
    Inflammatory Bowel Disease-related Behaviours [IBD-Bx] questionnaire: Development, validation, and prospective associations with fatigue.
    J Crohns Colitis. 2021 Oct 8. pii: 6383644. doi: 10.1093.
    PubMed     Abstract available


  120. JOJART B, Molnar T, Szabo V, Varga A, et al
    Erratum to: P459 Expression of SerpinE1, a potential new disease activity marker, reflects therapeutic response in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Oct 7. pii: 6383122. doi: 10.1093.
    PubMed    


  121. ADAMINA M, Fiorino G
    At the Crossroads of Caution and Intervention: Anti-TNF Therapy Prior to Elective CD Surgery.
    J Crohns Colitis. 2021;15:1778-1779.
    PubMed    


  122. MEKORI-DOMACHEVSKY E, Ben-Horin S
    Holistic approach to IBD patients.
    J Crohns Colitis. 2021;15:1782.
    PubMed    


  123. SOOP M, Hancock L, Davies J
    Anti-TNF Therapy Before Intestinal Surgery for Crohn's Disease and the Risks of Postoperative Complications.
    J Crohns Colitis. 2021;15:1777.
    PubMed    


  124. HONAP S, Irving PM, Kennedy NA
    Response to 'Clinical Efficacy of Tofacitinib in Moderate to Severe Ulcerative Colitis'.
    J Crohns Colitis. 2021;15:1775-1776.
    PubMed    


  125. RAINE T, Verstockt B, Kopylov U, Karmiris K, et al
    ECCO Topical Review: Refractory Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:1605-1620.
    PubMed     Abstract available


  126. UNGAR B, Malickova K, Hanzel J, Abu Arisha M, et al
    Dose optimisation for Loss of Response to Vedolizumab- Pharmacokinetics and Immune Mechanisms.
    J Crohns Colitis. 2021;15:1707-1719.
    PubMed     Abstract available


  127. VIEUJEAN S, Hu S, Bequet E, Salee C, et al
    Potential Role of Epithelial Endoplasmic Reticulum Stress and Anterior Gradient Protein 2 Homologue in Crohn's Disease Fibrosis.
    J Crohns Colitis. 2021;15:1737-1750.
    PubMed     Abstract available


  128. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Outcomes of Passable and Non-passable Strictures in Clinical Trials of Crohn's Disease: A Post-hoc Analysis.
    J Crohns Colitis. 2021;15:1649-1657.
    PubMed     Abstract available


  129. ILVEMARK JFKF, Hansen T, Goodsall TM, Seidelin JB, et al
    Defining transabdominal Intestinal Ultrasound treatment response and remission in Inflammatory Bowel Disease: Systematic review and expert consensus statement.
    J Crohns Colitis. 2021 Oct 6. pii: 6382324. doi: 10.1093.
    PubMed     Abstract available


  130. AARDOOM MA, Klomberg RCW, Kemos P, Ruemmele FM, et al
    The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry.
    J Crohns Colitis. 2021 Oct 2. pii: 6380289. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  131. RICCIUTO A, Lamb CA, Benchimol EI, Walker GJ, et al
    Inflammatory Bowel Disease Clinical Activity Is Associated with COVID-19 Severity Especially in Younger Patients.
    J Crohns Colitis. 2021 Sep 27. pii: 6376474. doi: 10.1093.
    PubMed     Abstract available


  132. DART RJ, Ellul P, Scharl M, Lamb CA, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD - Challenges and Future Directions.
    J Crohns Colitis. 2021;15:1407-1409.
    PubMed    


  133. FIOCCHI C, Dragoni G, Iliopoulos D, Katsanos K, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-What, Why, and How.
    J Crohns Colitis. 2021;15:1410-1430.
    PubMed     Abstract available


  134. VERSTOCKT B, Noor NM, Marigorta UM, Pavlidis P, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD-Disease Outcome and Response to Therapy.
    J Crohns Colitis. 2021;15:1431-1442.
    PubMed     Abstract available


  135. LI Y, Zhu L, Chen P, Wang Y, et al
    MALAT1 Maintains the Intestinal Mucosal Homeostasis in Crohn's Disease via the miR-146b-5p-CLDN11/NUMB Pathway.
    J Crohns Colitis. 2021;15:1542-1557.
    PubMed     Abstract available


  136. DE KRIJGER M, Wildenberg ME, Mookhoek A, Verheul S, et al
    Expression of MAdCAM-1 and Gut-homing T Cells in Inflamed Pouch Mucosa.
    J Crohns Colitis. 2021;15:1491-1499.
    PubMed     Abstract available


  137. RUSSO E, Giudici F, Ricci F, Scaringi S, et al
    Diving into Inflammation: A Pilot Study Exploring the Dynamics of the Immune-Microbiota Axis in Ileal Tissue Layers of Patients with Crohn's Disease.
    J Crohns Colitis. 2021;15:1500-1516.
    PubMed     Abstract available


  138. SOLA TAPIAS N, Denadai-Souza A, Rolland-Fourcade C, Quaranta-Nicaise M, et al
    Colitis Linked to Endoplasmic Reticulum Stress Induces Trypsin Activity Affecting Epithelial Functions.
    J Crohns Colitis. 2021;15:1528-1541.
    PubMed     Abstract available


  139. CHEN D, Fulmer C, Gordon IO, Syed S, et al
    Application of Artificial Intelligence to Clinical Practice in Inflammatory Bowel Disease - What the Clinician Needs to Know.
    J Crohns Colitis. 2021 Sep 24. pii: 6374854. doi: 10.1093.
    PubMed     Abstract available


  140. WONG D, Travis SPL
    Patient-reported Goals in Inflammatory Bowel Disease: What's the Problem?
    J Crohns Colitis. 2021 Sep 21. pii: 6373333. doi: 10.1093.
    PubMed    


  141. SARBAGILI SHABAT C, Scaldaferri F, Zittan E, Hirsch A, et al
    Use of Fecal transplantation with a novel diet for mild to moderate active ulcerative colitis: The CRAFT UC randomized controlled trial.
    J Crohns Colitis. 2021 Sep 13. pii: 6369227. doi: 10.1093.
    PubMed     Abstract available


  142. PHILLIPS F, Verstockt B, Ribaldone DG, Guerra I, et al
    Diagnosis and outcome of extranodal primary intestinal lymphoma in inflammatory bowel disease: an ECCO CONFER case series.
    J Crohns Colitis. 2021 Sep 11. pii: 6368841. doi: 10.1093.
    PubMed     Abstract available


  143. KIM GH, Lee YC, Kim TJ, Kim ER, et al
    Risk of neurodegenerative diseases in patients with inflammatory bowel disease: a nationwide population-based cohort study.
    J Crohns Colitis. 2021 Sep 9. pii: 6367800. doi: 10.1093.
    PubMed     Abstract available


  144. BOURGONJE AR, Hu S, Spekhorst LM, Zhernakova DV, et al
    The Effect of Phenotype and Genotype on the Plasma Proteome in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Sep 7. pii: 6365883. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  145. BOTS S, Nylund K, Gecse K
    Response to letter to the editor "Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index".
    J Crohns Colitis. 2021 Aug 14. pii: 6352305. doi: 10.1093.
    PubMed    


  146. CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Cluster Randomized Trials: Lessons for Inflammatory Bowel Disease Trials.
    J Crohns Colitis. 2021 Aug 14. pii: 6352195. doi: 10.1093.
    PubMed     Abstract available


  147. REUKEN PA, Andreas N, Grunert PC, Glockner S, et al
    T cell response after SARS-CoV-2 vaccination in immunocompromised patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348138. doi: 10.1093.
    PubMed     Abstract available


  148. CROWLEY E, Ma C, Andic M, Feagan BG, et al
    Impact of Drug Approval Pathways for Paediatric Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 11. pii: 6348023. doi: 10.1093.
    PubMed     Abstract available


  149. TSE CS, Van Citters AD, Ricci B, Freundlich NZ, et al
    Identifying and Predicting the Goals and Concerns Prioritized by Individuals with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Aug 5. pii: 6341120. doi: 10.1093.
    PubMed     Abstract available


  150. CARVELLO M, Bellato V, Maroli A, Hart A, et al
    A multidisciplinary approach to rectal cancer treatment in ulcerative colitis results in high rate of restorative minimally invasive surgery.
    J Crohns Colitis. 2021 Aug 4. pii: 6338719. doi: 10.1093.
    PubMed     Abstract available


  151. PROIETTI E, Fuhler GM, Peppelenbosch MP
    Mycobacterium Avium Subspecies Paratuberculosis Infection and Biological Treatment of IBD: Cause or Consequence?
    J Crohns Colitis. 2021;15:1247-1249.
    PubMed    


  152. WELLENS J, Colombel JF, Satsangi JJ, Wong SY, et al
    SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
    J Crohns Colitis. 2021;15:1376-1386.
    PubMed     Abstract available


  153. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Statin Use and Risk of Inflammatory Bowel Diseases: Authors' Reply.
    J Crohns Colitis. 2021;15:1403-1404.
    PubMed    


  154. TURSI A, Mocci G, Maconi G
    Effect of Ustekinumab on Extraintestinal Diseases in Refractory Crohn's Disease.
    J Crohns Colitis. 2021;15:1399-1400.
    PubMed    


  155. CARON B, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Endpoints for Perianal Crohn's Disease Trials: Past, Present and Future.
    J Crohns Colitis. 2021;15:1387-1398.
    PubMed     Abstract available


  156. ELLRICHMANN M, Bethge J, Boesenkoetter J, Conrad C, et al
    Subclinical Pulmonary Involvement in Active IBD Responds to Biologic Therapy.
    J Crohns Colitis. 2021;15:1339-1345.
    PubMed     Abstract available


  157. CAER C, Gorreja F, Forsskahl SK, Brynjolfsson SF, et al
    TREM-1+ Macrophages Define a Pathogenic Cell Subset in the Intestine of Crohn's Disease Patients.
    J Crohns Colitis. 2021;15:1346-1361.
    PubMed     Abstract available


  158. CAMBI MPC, Yamamoto T, Kotze PG
    Importance of Nutrition and Hypoalbuminaemia in Postoperative Morbidity in Crohn's Disease: Thinking Outside of the Box on Biologics as Single Risk Factors.
    J Crohns Colitis. 2021;15:1401-1402.
    PubMed    


  159. CHANG I, Park S, Lee HJ, Kim I, et al
    Interpretation of XIAP Variants of Uncertain Significance in Paediatric Patients with Refractory Crohn's Disease.
    J Crohns Colitis. 2021;15:1291-1304.
    PubMed     Abstract available


  160. PETERS V, Spooren CEGM, Pierik MJ, Weersma RK, et al
    Dietary Intake Pattern is Associated with Occurrence of Flares in IBD Patients.
    J Crohns Colitis. 2021;15:1305-1315.
    PubMed     Abstract available


    July 2021
  161. SEDANO R, Hogan M, Nguyen TM, Chang J, et al
    Systematic review and Meta-analysis: Clinical, Endoscopic, Histologic and Safety Placebo Rates in Induction and Maintenance trials of Ulcerative Colitis.
    J Crohns Colitis. 2021 Jul 26. pii: 6328606. doi: 10.1093.
    PubMed     Abstract available


  162. PARK SH, Im JP, Park H, Jeong SK, et al
    Clinical features and long-term outcomes of pediatric-onset inflammatory bowel disease in a population-based cohort in the Songpa-Kangdong district of Seoul, Korea.
    J Crohns Colitis. 2021 Jul 26. pii: 6328476. doi: 10.1093.
    PubMed     Abstract available


  163. BOSSUYT P, Pouillon L, Claeys S, D'Haens S, et al
    Ultra-proactive therapeutic drug monitoring of infliximab based on point-of-care-testing in inflammatory bowel disease: results of a pragmatic trial.
    J Crohns Colitis. 2021 Jul 23. pii: 6326544. doi: 10.1093.
    PubMed     Abstract available


  164. CHEE D, Nice R, Hamilton B, Jones E, et al
    Patient-led Remote IntraCapillary pharmacoKinetic Sampling (fingerPRICKS) for therapeutic drug monitoring in patients with inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 21. pii: 6325142. doi: 10.1093.
    PubMed     Abstract available


  165. DIEZ-OBRERO V, Moratalla-Navarro F, Ibanez-Sanz G, Guardiola J, et al
    Transcriptome-wide association study for inflammatory bowel disease reveals novel candidate susceptibility genes in specific colon subsites and tissue categories.
    J Crohns Colitis. 2021 Jul 21. pii: 6324884. doi: 10.1093.
    PubMed     Abstract available


  166. ZITTAN E, Steinhart AH, Aran H, Milgrom R, et al
    The Toronto Ibd Global Endoscopic Reporting (Tiger) Score: A Single, Easy To Use Endoscopic Score For Both Crohn's Disease And Ulcerative Colitis Patients.
    J Crohns Colitis. 2021 Jul 17. pii: 6323260. doi: 10.1093.
    PubMed     Abstract available


  167. DINALLO V, Di Fusco D, Di Grazia A, Laudisi F, et al
    The deubiquitinating enzyme OTUD5 sustains inflammatory cytokine response in inflammatory bowel disease.
    J Crohns Colitis. 2021 Jul 7. pii: 6316763. doi: 10.1093.
    PubMed     Abstract available


  168. CHOI WT, Salomao M, Zhao L, Alpert L, et al
    Hypermucinous, Goblet Cell Deficient, and Crypt Cell Dysplasias in Inflammatory Bowel Disease are Often Associated with Flat/Invisible Endoscopic Appearance and Advanced Neoplasia on Follow-Up.
    J Crohns Colitis. 2021 Jul 7. pii: 6316756. doi: 10.1093.
    PubMed     Abstract available


  169. DELISLE M, Wilkens R, Novak KL
    Keeping It Simple: Using Intestinal Ultrasound to Assess Ulcerative Colitis with a Novel UC-Ultrasound Index.
    J Crohns Colitis. 2021 Jul 5. pii: 6315708. doi: 10.1093.
    PubMed    


  170. RESTELLINI S, Lakatos PL
    Patient-Reported Outcomes in Inflammatory Bowel Diseases: Another Piece in the Puzzle.
    J Crohns Colitis. 2021;15:1085-1086.
    PubMed    


  171. GUPTA V, Mohsen W, Chapman TP, Satsangi J, et al
    Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021.
    J Crohns Colitis. 2021;15:1211-1221.
    PubMed     Abstract available


  172. DAI C, Jiang M, Huang YH
    Association Between Statin Use and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2021;15:1246.
    PubMed    


  173. ADAMINA M, Feakins R, Iacucci M, Spinelli A, et al
    ECCO Topical Review Optimising Reporting in Surgery, Endoscopy, and Histopathology.
    J Crohns Colitis. 2021;15:1089-1105.
    PubMed     Abstract available


  174. XU M, Shen Y, Cen M, Zhu Y, et al
    Modulation of the Gut Microbiota-farnesoid X Receptor Axis Improves Deoxycholic Acid-induced Intestinal Inflammation in Mice.
    J Crohns Colitis. 2021;15:1197-1210.
    PubMed     Abstract available


  175. LI XH, Feng ST, Cao QH, Coffey JC, et al
    Degree of Creeping Fat Assessed by Computed Tomography Enterography is Associated with Intestinal Fibrotic Stricture in Patients with Crohn's Disease: A Potentially Novel Mesenteric Creeping Fat Index.
    J Crohns Colitis. 2021;15:1161-1173.
    PubMed     Abstract available


  176. KIM PH, Kim SH, Cho YA, Yoon HM, et al
    Ability of Pelvic Magnetic Resonance Imaging to Predict Clinical Course of Perianal Fistula in Paediatric Crohn's Disease Patients.
    J Crohns Colitis. 2021;15:1152-1160.
    PubMed     Abstract available


  177. SHAH RS, Bachour S, Jia X, Holubar SD, et al
    Hypoalbuminaemia, Not Biologic Exposure, Is Associated with Postoperative Complications in Crohn's Disease Patients Undergoing Ileocolic Resection.
    J Crohns Colitis. 2021;15:1142-1151.
    PubMed     Abstract available


  178. POLETTI M, Arnauts K, Ferrante M, Korcsmaros T, et al
    Organoid-based Models to Study the Role of Host-microbiota Interactions in IBD.
    J Crohns Colitis. 2021;15:1222-1235.
    PubMed     Abstract available


  179. WONG ECL, Buffone E, Lee SJ, Dulai PS, et al
    End of Induction Patient-reported Outcomes Predict Clinical Remission but Not Endoscopic Remission in Crohn's Disease.
    J Crohns Colitis. 2021;15:1114-1119.
    PubMed     Abstract available


  180. COX SR, Clarke H, O'Keeffe M, Dubois P, et al
    Nutrient, fibre and FODMAP intakes and food-related quality of life in patients with inflammatory bowel disease and their relationship with gastrointestinal symptoms of differing aetiologies.
    J Crohns Colitis. 2021 Jul 3. pii: 6314229. doi: 10.1093.
    PubMed     Abstract available


    June 2021
  181. WATANABE S, Hibiya S, Katsukura N, Kitagawa S, et al
    Importance of telomere shortening in the pathogenesis of ulcerative colitis: A new treatment from the aspect of telomeres in intestinal epithelial cells.
    J Crohns Colitis. 2021 Jun 28. pii: 6310549. doi: 10.1093.
    PubMed     Abstract available


  182. GUBATAN J, Rubin SJS, Bai L, Haileselassie Y, et al
    Vitamin D is Associated with alpha4beta7+ Immunophenotypes and Predicts Vedolizumab Therapy Failure in Patients with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Jun 28. pii: 6310486. doi: 10.1093.
    PubMed     Abstract available


  183. KUENZIG ME, Bitton A, Carroll MW, Kaplan GG, et al
    Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study.
    J Crohns Colitis. 2021 Jun 27. pii: 6310166. doi: 10.1093.
    PubMed     Abstract available


  184. KIM PH, Yoon HM, Jung AY, Lee JS, et al
    Diagnostic Performance of Diffusion-weighted Imaging for Evaluation of Bowel Inflammation in Pediatric Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308099. doi: 10.1093.
    PubMed     Abstract available


  185. GILMORE R, Hilley P, Srinivasan A, Choy M, et al
    Sequential use of high-dose tofacitinib after infliximab salvage therapy in acute severe ulcerative colitis.
    J Crohns Colitis. 2021 Jun 22. pii: 6308093. doi: 10.1093.
    PubMed     Abstract available


  186. ABAKKOUY Y, Cleynen I
    The Promise of Polygenic Risk Scores as a Research Tool to Analyse the Genetics Underlying IBD Phenotypes.
    J Crohns Colitis. 2021;15:877-878.
    PubMed    


  187. ATTAUABI M, Seidelin JB, Burisch J
    Authors' Reply to: 'COVID-19 in the IBD Population: The Need for Correct Nomenclature'.
    J Crohns Colitis. 2021;15:1080.
    PubMed    


  188. STOCKER D, King MJ, El Homsi M, Carbonell G, et al
    Luminal Narrowing Alone Allows an Accurate Diagnosis of Crohn's Disease Small Bowel Strictures at Cross-Sectional Imaging.
    J Crohns Colitis. 2021;15:1009-1018.
    PubMed     Abstract available


  189. BUISSON A, Filippi J, Amiot A, Cadiot G, et al
    Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.
    J Crohns Colitis. 2021;15:1000-1008.
    PubMed     Abstract available


  190. SYAL G, Shemtov R, Bonthala N, Vasiliauskas EA, et al
    Pre-pouch Ileitis is Associated with Development of Crohn's Disease-like Complications and Pouch Failure.
    J Crohns Colitis. 2021;15:960-968.
    PubMed     Abstract available


  191. GIANOTTI RJ, Cheifetz AS
    Cannabis and Inflammatory Bowel Disease: All Smoke and Mirrors?
    J Crohns Colitis. 2021 Jun 17. pii: 6301791. doi: 10.1093.
    PubMed    


  192. JOHNSON AM, Harmsen WS, Aniwan S, Tremaine WJ, et al
    Prevalence and Impact of Obesity on Disease-Specific Outcomes in a Population-Based Cohort of Patients with Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 12. pii: 6297429. doi: 10.1093.
    PubMed     Abstract available


  193. PORTER RJ, Arends MJ, Churchhouse AMD, Din S, et al
    Inflammatory bowel disease-associated colorectal cancer: translational risks from mechanisms to medicines.
    J Crohns Colitis. 2021 Jun 10. pii: 6295922. doi: 10.1093.
    PubMed     Abstract available


  194. GHOSH S, Sanchez Gonzalez Y, Zhou W, Clark R, et al
    Upadacitinib Treatment Improves Symptoms of Bowel Urgency and Abdominal Pain, and Correlates With Quality of Life Improvements in Patients With Moderate to Severe Ulcerative Colitis.
    J Crohns Colitis. 2021 Jun 9. pii: 6295522. doi: 10.1093.
    PubMed     Abstract available


  195. HERNANDEZ-ROCHA C, Borowski K, Turpin W, Filice M, et al
    Integrative analysis of colonic biopsies from inflammatory bowel disease patients identifies an interaction between microbial bile-acid inducible gene abundance and human Angiopoietin-like 4 gene expression.
    J Crohns Colitis. 2021 Jun 2. pii: 6291049. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  196. FUMERY M, Chatelain D
    Histological Scores in Inflammatory Bowel Disease: A New Kid in the Block.
    J Crohns Colitis. 2021 May 27. pii: 6286012. doi: 10.1093.
    PubMed    


  197. DHERI AK, Kuenzig ME, Mack DR, Murthy SK, et al
    Shifting health care use from hospitalizations and surgeries to outpatient visits in children with inflammatory bowel disease: a population-based cohort study from Ontario, Canada.
    J Crohns Colitis. 2021 May 21. pii: 6279878. doi: 10.1093.
    PubMed     Abstract available


  198. WEISSMAN S, Patel K, Kolli S, Lipcsey M, et al
    Obesity in Inflammatory Bowel Disease is Associated with Early Readmissions characterized by an Increased Systems and Patient-level Burden.
    J Crohns Colitis. 2021 May 17. pii: 6276891. doi: 10.1093.
    PubMed     Abstract available


  199. REZAZADEH ARDABILI A, Creemers RH, van Bodegraven AA
    COVID-19 in the IBD Population: The Need for Correct Nomenclature.
    J Crohns Colitis. 2021;15:872-873.
    PubMed    


  200. BERTE' R, Mazza S, Stefanucci MR, Noviello D, et al
    Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy.
    J Crohns Colitis. 2021;15:864-868.
    PubMed     Abstract available


  201. REZAZADEH ARDABILI A, Hendrix EMB, Pierik MJ
    Remote Monitoring of Inflammatory Bowel Disease: What Kind of Patient-Reported Questionnaires Should We Use?
    J Crohns Colitis. 2021;15:869-870.
    PubMed    


  202. CROSBY S, Schuh MJ, Farraye FA
    Rechallenge with Subcutaneous Ustekinumab After Hypersensitivity Reaction to Intravenous Ustekinumab.
    J Crohns Colitis. 2021;15:871.
    PubMed    


  203. ASHTON JJ, Boukas K, Davies J, Stafford IS, et al
    Ileal Transcriptomic Analysis in Paediatric Crohn's Disease Reveals IL17- and NOD-signalling Expression Signatures in Treatment-naive Patients and Identifies Epithelial Cells Driving Differentially Expressed Genes.
    J Crohns Colitis. 2021;15:774-786.
    PubMed     Abstract available


  204. LOCHHEAD P, Khalili H, Sachs MC, Chan AT, et al
    Association Between Statin Use and Inflammatory Bowel Diseases: Results from a Swedish, Nationwide, Population-based Case-control Study.
    J Crohns Colitis. 2021;15:757-765.
    PubMed     Abstract available


  205. KLANG E, Grinman A, Soffer S, Margalit Yehuda R, et al
    Automated Detection of Crohn's Disease Intestinal Strictures on Capsule Endoscopy Images Using Deep Neural Networks.
    J Crohns Colitis. 2021;15:749-756.
    PubMed     Abstract available


  206. MOTTA JP, Palese S, Giorgio C, Chapman K, et al
    Increased Mucosal Thrombin is Associated with Crohn's Disease and Causes Inflammatory Damage through Protease-activated Receptors Activation.
    J Crohns Colitis. 2021;15:787-799.
    PubMed     Abstract available


  207. NELSON A, Stewart CJ, Kennedy NA, Lodge JK, et al
    The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals Without Gastrointestinal Inflammation.
    J Crohns Colitis. 2021;15:800-812.
    PubMed     Abstract available


  208. MULLER M, D'Amico F, Bonovas S, Danese S, et al
    TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review.
    J Crohns Colitis. 2021;15:840-859.
    PubMed     Abstract available


    April 2021
  209. VAN ERP LW, van Gerven J, Bloem S, Groenen MJM, et al
    Acceptance and perceived control are independently associated with quality of life in inflammatory bowel disease: Introduction of a new segmentation model.
    J Crohns Colitis. 2021 Apr 28. pii: 6257076. doi: 10.1093.
    PubMed     Abstract available


  210. STRAATMIJER T, Biemans VBC, Hoentjen F, de Boer NKH, et al
    Ustekinumab for Crohn's Disease: Two-Year Results of the Initiative on Crohn and Colitis (ICC) Registry, a Nationwide Prospective Observational Cohort Study.
    J Crohns Colitis. 2021 Apr 28. pii: 6256992. doi: 10.1093.
    PubMed     Abstract available


  211. OUAHED J, Kelsen JR, Spessott WA, Kooshesh K, et al
    Variants in STXBP3 Are Associated With Very Early Onset Inflammatory Bowel Disease, Bilateral Sensorineural Hearing Loss and Immune Dysregulation.
    J Crohns Colitis. 2021 Apr 23. pii: 6247960. doi: 10.1093.
    PubMed     Abstract available


  212. SLEIMAN J, Hitawala AA, Cohen B, Falloon K, et al
    Systematic review: Sweet syndrome associated with inflammatory bowel disease.
    J Crohns Colitis. 2021 Apr 23. pii: 6247949. doi: 10.1093.
    PubMed     Abstract available


  213. UNTERWEGER AL, Jensen MO, Giordanetto F, Jogini V, et al
    Suppressing Kv1.3 Ion Channel Activity with a Novel Small Molecule Inhibitor Ameliorates Inflammation in a Humanized Mouse Model of Ulcerative Colitis.
    J Crohns Colitis. 2021 Apr 23. pii: 6247959. doi: 10.1093.
    PubMed     Abstract available


  214. PANES J, Vermeire S, Dubinsky MC, Loftus EV, et al
    Efficacy and Safety of Tofacitinib Retreatment for Ulcerative Colitis After Treatment Interruption: Results From the OCTAVE Clinical Trials.
    J Crohns Colitis. 2021 Apr 22. pii: 6245086. doi: 10.1093.
    PubMed     Abstract available


  215. CHAPARRO M, Garre A, Iborra M, Sierra M, et al
    Effectiveness and safety of ustekinumab in ulcerative colitis: Real-world evidence from the ENEIDA registry.
    J Crohns Colitis. 2021 Apr 16. pii: 6228235. doi: 10.1093.
    PubMed     Abstract available


  216. JUNG S, Ye BD, Lee HS, Baek J, et al
    Identification of three novel susceptibility loci for inflammatory bowel disease in Koreans in an extended genome-wide association study.
    J Crohns Colitis. 2021 Apr 14. pii: 6225940. doi: 10.1093.
    PubMed     Abstract available


  217. FUMERY M, Yzet C, Chatelain D, Yzet T, et al
    Colonic strictures in inflammatory bowel disease: epidemiology, complications, and management.
    J Crohns Colitis. 2021 Apr 12. pii: 6222697. doi: 10.1093.
    PubMed     Abstract available


  218. ATTAR A, Branche J, Coron E, Privat J, et al
    An Anti-migration Self-expandable and Removable Metal Stent for Crohn's Disease Strictures: A Nationwide Study From GETAID and SFED.
    J Crohns Colitis. 2021;15:521-528.
    PubMed     Abstract available


  219. NOVAK KL, Nylund K, Maaser C, Petersen F, et al
    Expert Consensus on Optimal Acquisition and Development of the International Bowel Ultrasound Segmental Activity Score [IBUS-SAS]: A Reliability and Inter-rater Variability Study on Intestinal Ultrasonography in Crohn's Disease.
    J Crohns Colitis. 2021;15:609-616.
    PubMed     Abstract available


  220. ZHAO J, Wang H, Zhou J, Qian J, et al
    miR-130a-3p, a Preclinical Therapeutic Target for Crohn's Disease.
    J Crohns Colitis. 2021;15:647-664.
    PubMed     Abstract available


  221. DE VRIES LCS, Ghiboub M, van Hamersveld PHP, Welting O, et al
    Tyrosine Kinase 2 Signalling Drives Pathogenic T cells in Colitis.
    J Crohns Colitis. 2021;15:617-630.
    PubMed     Abstract available


  222. CON D, Parthasarathy N, Bishara M, Luber RP, et al
    Development of a Simple, Serum Biomarker-based Model Predictive of the Need for Early Biologic Therapy in Crohn's Disease.
    J Crohns Colitis. 2021;15:583-593.
    PubMed     Abstract available


  223. HUGOT JP, Dumay A, Barreau F, Meinzer U, et al
    Crohn's Disease: Is the Cold Chain Hypothesis Still Hot?
    J Crohns Colitis. 2021;15:678-686.
    PubMed     Abstract available


  224. LUND K, Larsen MD, Knudsen T, Kjeldsen J, et al
    Infliximab, Immunomodulators and Treatment Failures in Paediatric and Adolescent Patients with Crohn's Disease: a Nationwide Cohort Study.
    J Crohns Colitis. 2021;15:575-582.
    PubMed     Abstract available


  225. VERSTOCKT B, Pouillon L, Bossuyt P
    Tofacitinib and Subacute Pneumonitis: Don't Hold Your Breath.
    J Crohns Colitis. 2021;15:692-693.
    PubMed    


  226. RUTKA M, Pigniczki D, Molnar T
    Tofacitinib Therapy, the Lender of Last Resort.
    J Crohns Colitis. 2021;15:694.
    PubMed    


  227. D'AMICO F, Guillo L, Baumann C, Danese S, et al
    Histological disease activity measured by the Nancy index is associated with long-term outcomes in patients with ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211061. doi: 10.1093.
    PubMed     Abstract available


  228. NG A
    Clinical efficacy of tofacitinib in moderate to severe ulcerative colitis.
    J Crohns Colitis. 2021 Apr 5. pii: 6211060. doi: 10.1093.
    PubMed    


    March 2021
  229. BRESSLER B, Yarur A, Silverberg MS, Bassel M, et al
    Vedolizumab and Anti-TNFalpha Real-World Outcomes in Biologic-Naive Inflammatory Bowel Disease Patients: Results from the EVOLVE Study.
    J Crohns Colitis. 2021 Mar 31. pii: 6205394. doi: 10.1093.
    PubMed     Abstract available


  230. LANG-SCHWARZ C, Angeloni M, Agaimy A, Atreya R, et al
    Validation of the "Inflammatory Bowel Disease - Distribution, Chronicity, Activity (IBD-DCA) Score" for Ulcerative Colitis and Crohn s disease.
    J Crohns Colitis. 2021 Mar 27. pii: 6196021. doi: 10.1093.
    PubMed     Abstract available


  231. PALMIERI C, Muller G, Kroesen AJ, Galata C, et al
    Perianal fistula-associated carcinoma in Crohn s disease: a multicenter retrospective case control study.
    J Crohns Colitis. 2021 Mar 27. pii: 6189787. doi: 10.1093.
    PubMed     Abstract available


  232. NORSA L, Berni Canani R, Duclaux-Loras R, Bequet E, et al
    Inflammatory bowel disease in patients with congenital chloride diarrhoea.
    J Crohns Colitis. 2021 Mar 26. pii: 6189668. doi: 10.1093.
    PubMed     Abstract available


  233. RUDDY J, Taft T, Keszthelyi D
    Gut-Brain Interactions in patients with Inflammatory Bowel Disease (IBD) and the role of Hypnotherapy in Managing Symptoms.
    J Crohns Colitis. 2021 Mar 18. pii: 6175701. doi: 10.1093.
    PubMed    


  234. TORRES J, Halfvarson J, Rodriguez-Lago I, Hedin CRH, et al
    Results of the Seventh Scientific Workshop of ECCO: Precision medicine in IBD- prediction and prevention of inflammatory bowel disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175312. doi: 10.1093.
    PubMed     Abstract available


  235. KUCHARZIK T, Ellul P, Greuter T, Rahier JF, et al
    ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Mar 17. pii: 6175313. doi: 10.1093.
    PubMed    


  236. PIOVANI D, Pansieri C, Kotha SRR, Piazza AC, et al
    Ethnic Differences in the Smoking-Related Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Crohns Colitis. 2021 Mar 15. pii: 6171987. doi: 10.1093.
    PubMed     Abstract available


  237. VERSTOCKT B, Verstockt S, Abdu Rahiman S, Ke BJ, et al
    Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon.
    J Crohns Colitis. 2021;15:485-498.
    PubMed     Abstract available


  238. COLLARD MK, Benoist S, Maggiori L, Zerbib P, et al
    A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn's Disease: A Subgroup Analysis of a Nationwide Prospective Cohort.
    J Crohns Colitis. 2021;15:409-418.
    PubMed     Abstract available


  239. RICCIUTO A, Mack DR, Huynh HQ, Jacobson K, et al
    Diagnostic Delay Is Associated With Complicated Disease and Growth Impairment in Paediatric Crohn's Disease.
    J Crohns Colitis. 2021;15:419-431.
    PubMed     Abstract available


  240. MOREAU J, Hammoudi N, Marthey L, Trang-Poisson C, et al
    Impact of an Education Programme on IBD Patients' Skills: Results of a Randomised Controlled Multicentre Study [ECIPE].
    J Crohns Colitis. 2021;15:432-440.
    PubMed     Abstract available


  241. NARULA N, Wong ECL, Dulai PS, Marshall JK, et al
    Week 6 Calprotectin Best Predicts Likelihood of Long-term Endoscopic Healing in Crohn's Disease: A Post-hoc Analysis of the UNITI/IM-UNITI Trials.
    J Crohns Colitis. 2021;15:462-470.
    PubMed     Abstract available


  242. BARELLO S, Guida E, Bonanomi A, Menichetti J, et al
    WE-CARE IBD SCORE: Assessing High-quality Care From the Perspective of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2021;15:349-357.
    PubMed     Abstract available


  243. WINTJENS D, Bergey F, Saccenti E, Jeuring S, et al
    Disease Activity Patterns of Crohn's Disease in the First Ten Years After Diagnosis in the Population-based IBD South Limburg Cohort.
    J Crohns Colitis. 2021;15:391-400.
    PubMed     Abstract available


  244. FOURIE S, Norton C, Jackson D, Czuber-Dochan W, et al
    'These discussions aren't happening'. Experiences of people living with inflammatory bowel disease talking about sexual well-being with healthcare professionals.
    J Crohns Colitis. 2021 Mar 4. pii: 6158978. doi: 10.1093.
    PubMed     Abstract available


  245. PAI RK, Hartman DJ, Leighton JA, Shabana PF, et al
    Validated Indices for Histopathologic Activity Predict Development of Colorectal Neoplasia in Ulcerative Colitis.
    J Crohns Colitis. 2021 Mar 4. pii: 6158975. doi: 10.1093.
    PubMed     Abstract available


  246. ATREYA R, Neurath MF
    Can Serum Proteomic Profiling Annunciate Individual Disease Progression in Newly Diagnosed Inflammatory Bowel Disease Patients?
    J Crohns Colitis. 2021 Mar 2. pii: 6156783. doi: 10.1093.
    PubMed    


    February 2021
  247. LUDVIGSSON JF, Olen O, Larsson H, Halfvarson J, et al
    Association between inflammatory bowel disease and psychiatric morbidity and suicide: A Swedish nationwide population-based cohort study with sibling comparisons.
    J Crohns Colitis. 2021 Feb 26. pii: 6153473. doi: 10.1093.
    PubMed     Abstract available


  248. GUILLO L, Peyrin-Biroulet L, Louis E
    Tofacitinib De-escalation Strategy in Ulcerative Colitis: Is It the End of the Story?
    J Crohns Colitis. 2021 Feb 23. pii: 6146725. doi: 10.1093.
    PubMed    


  249. ALLIN KH, Jacobsen RK, Ungaro RC, Colombel JF, et al
    Bariatric surgery and risk of new-onset inflammatory bowel disease: A nationwide cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145790. doi: 10.1093.
    PubMed     Abstract available


  250. GOETGEBUER RL, Kreijne JE, Aitken CA, Dijkstra G, et al
    Increased risk of high-grade cervical neoplasia in women with inflammatory bowel disease: a case-controlled cohort study.
    J Crohns Colitis. 2021 Feb 20. pii: 6145789. doi: 10.1093.
    PubMed     Abstract available


  251. REINISCH W, Sandborn WJ, Danese S, Hebuterne X, et al
    Long-term safety and efficacy of the anti-MAdCAM-1 monoclonal antibody ontamalimab (SHP647) for the treatment of ulcerative colitis: the open-label study TURANDOT II.
    J Crohns Colitis. 2021 Feb 18. pii: 6144575. doi: 10.1093.
    PubMed     Abstract available


  252. ARAKI T, Mitsuyama K, Yamasaki H, Morita M, et al
    Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141509. doi: 10.1093.
    PubMed     Abstract available


  253. ACKERMANN M, Mucci A, McCabe A, Frei S, et al
    Restored macrophage function ameliorates disease pathophysiology in a mouse model for IL10 receptor deficient very early onset inflammatory bowel disease.
    J Crohns Colitis. 2021 Feb 17. pii: 6141466. doi: 10.1093.
    PubMed     Abstract available


  254. WATANABE S, Nishimura R, Shirasaki T, Katsukura N, et al
    Schlafen 11 is a novel target for mucosal regeneration in Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 17. pii: 6141476. doi: 10.1093.
    PubMed     Abstract available


  255. ZHAO M, Gonczi L, Lakatos PL, Burisch J, et al
    The burden of inflammatory bowel disease in Europe in 2020.
    J Crohns Colitis. 2021 Feb 14. pii: 6134782. doi: 10.1093.
    PubMed     Abstract available


  256. BARNES EL, Holubar SD, Herfarth HH
    Systematic Review and Meta-Analysis of Outcomes after Ileal Pouch-Anal Anastomosis in Primary Sclerosing Cholangitis-Ulcerative Colitis.
    J Crohns Colitis. 2021 Feb 5. pii: 6129144. doi: 10.1093.
    PubMed     Abstract available


  257. GHOSH S, Iacucci M
    Measuring Patient Experience in Inflammatory Bowel Disease Care: A Key Component of Continuous Quality Improvement.
    J Crohns Colitis. 2021 Feb 5. pii: 6129099. doi: 10.1093.
    PubMed    


    January 2021
  258. RUIGROK RAAA, Collij V, Sureda P, Klaassen MAY, et al
    The composition and metabolic potential of the human small intestinal microbiota within the context of inflammatory bowel disease.
    J Crohns Colitis. 2021 Jan 30. pii: 6123997. doi: 10.1093.
    PubMed     Abstract available


  259. GRIM C, Noble R, Uribe G, Khanipov K, et al
    Impairment of tissue resident mesenchymal stem cells in chronic ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2021 Jan 28. pii: 6121690. doi: 10.1093.
    PubMed     Abstract available


  260. ALLOCCA M, Bonovas S, Danese S
    Letter to the Editor Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 25. pii: 6119566. doi: 10.1093.
    PubMed    


  261. LOVE BL, Finney CJ, Gaidos JKJ
    Effectiveness of Conjugate and Polysaccharide Pneumococcal Vaccines for Prevention of Severe Pneumococcal Disease Among Inflammatory Bowel Disease Patients.
    J Crohns Colitis. 2021 Jan 25. pii: 6118663. doi: 10.1093.
    PubMed     Abstract available


  262. VERMEIRE S, Chiorean M, Panes J, Peyrin-Biroulet L, et al
    Long-term Safety and Efficacy of Etrasimod for Ulcerative Colitis: Results from the Open-label Extension of the OASIS Study.
    J Crohns Colitis. 2021 Jan 21. pii: 6105062. doi: 10.1093.
    PubMed     Abstract available


  263. ZAIATZ BITTENCOURT V, Jones F, Tosetto M, Doherty GA, et al
    Dysregulation of metabolic pathways in circulating natural killer cells isolated from inflammatory bowel disease patients.
    J Crohns Colitis. 2021 Jan 18. pii: 6103919. doi: 10.1093.
    PubMed     Abstract available


  264. SANDBORN WJ, Feagan BG, Hanauer S, Vermeire S, et al
    Long-Term Efficacy And Safety Of Ozanimod In Moderate-To-Severe Ulcerative Colitis: Results From The Open-Label Extension Of The Randomized, Phase 2 Touchstone Study.
    J Crohns Colitis. 2021 Jan 13. pii: 6092404. doi: 10.1093.
    PubMed     Abstract available


  265. EFFENBERGER M, Reider S, Waschina S, Bronowski C, et al
    Microbial Butyrate Synthesis Indicates Therapeutic Efficacy of Azathioprine in IBD Patients.
    J Crohns Colitis. 2021;15:88-98.
    PubMed     Abstract available


  266. LEE S, Kuenzig ME, Ricciuto A, Zhang Z, et al
    Smoking May Reduce the Effectiveness of Anti-TNF Therapies to Induce Clinical Response and Remission in Crohn's Disease: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2021;15:74-87.
    PubMed     Abstract available


  267. THOMAS PWA, Ferwerda G, West RL, Hoentjen F, et al
    Immediate Infusion Reaction to Intravenous Ustekinumab in Three Crohn's Disease Patients: A Case Report and Review of the Literature.
    J Crohns Colitis. 2021;15:162-164.
    PubMed     Abstract available


  268. WEWER MD, Zhao M, Nordholm-Carstensen A, Weimers P, et al
    The Incidence and Disease Course of Perianal Crohn's Disease: A Danish Nationwide Cohort Study, 1997-2015.
    J Crohns Colitis. 2021;15:5-13.
    PubMed     Abstract available


  269. DE CAMPOS RJDS, Lucchetti G, Lucchetti ALG, Chebli LA, et al
    Influence of Religiousness and Spirituality on Remission Rate, Mental Health, and Quality of Life of Patients With Active Crohn's Disease: A Longitudinal 2-Year Follow-up Study.
    J Crohns Colitis. 2021;15:55-63.
    PubMed     Abstract available


  270. ZOLLNER A, Schmiderer A, Reider SJ, Oberhuber G, et al
    Faecal Biomarkers in Inflammatory Bowel Diseases: Calprotectin Versus Lipocalin-2-a Comparative Study.
    J Crohns Colitis. 2021;15:43-54.
    PubMed     Abstract available


  271. SAEVIK F, Eriksen R, Eide GE, Gilja OH, et al
    Development and Validation of a Simple Ultrasound Activity Score for Crohn's Disease.
    J Crohns Colitis. 2021;15:115-124.
    PubMed     Abstract available


  272. D'AMICO F, Nancey S, Danese S, Peyrin-Biroulet L, et al
    A Practical Guide for Faecal Calprotectin Measurement: Myths and Realities.
    J Crohns Colitis. 2021;15:152-161.
    PubMed     Abstract available


  273. KUCHARZIK T, Maaser C, Maconi G
    A Simple Intestinal Ultrasound Score in Crohn's Disease: First Big Step Towards New Paradigms.
    J Crohns Colitis. 2021;15:3-4.
    PubMed    


  274. MAASER C, Kucharzik T, Gecse K
    Is Intestinal Ultrasound Ready to be Used as Standard Monitoring Tool in Daily Practice and as Endpoint in Clinical Trials?
    J Crohns Colitis. 2021;15:1-2.
    PubMed    


  275. DAI C, Jiang M, Huang YH
    Anti-Tubercular Therapy on the Long-Term Disease Course of Patients with Crohn's disease.
    J Crohns Colitis. 2021;15:169.
    PubMed    


  276. BARBERIO B, Segal JP, Quraishi MN, Black CJ, et al
    Efficacy of Oral, Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2021 Jan 12. pii: 6089122. doi: 10.1093.
    PubMed     Abstract available


  277. DE VOOGD F, Wilkens R, Gecse K, Allocca M, et al
    A reliability study - strong inter-observer agreement of an expert panel for intestinal ultrasound in ulcerative colitis.
    J Crohns Colitis. 2021 Jan 9. pii: 6073674. doi: 10.1093.
    PubMed     Abstract available


  278. BOTS S, Nylund K, Lowenberg M, Gecse K, et al
    Intestinal Ultrasound to Assess Disease Activity in Ulcerative Colitis: Development of a novel UC-Ultrasound index.
    J Crohns Colitis. 2021 Jan 7. pii: 6067606. doi: 10.1093.
    PubMed     Abstract available


    December 2020
  279. VAN DER SLOOT KWJ, Voskuil MD, Blokzijl T, Dinkla A, et al
    Isotype specific antibody responses to Mycobacterium Avium subspecies Paratuberculosis antigens are associated with the use of biological therapy in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Dec 30. pii: 6055607. doi: 10.1093.
    PubMed     Abstract available


  280. GUILLO L, D'Amico F, Danese S, Peyrin-Biroulet L, et al
    Ustekinumab for extra-intestinal manifestations of inflammatory bowel disease: a systematic literature review.
    J Crohns Colitis. 2020 Dec 24. pii: 6046385. doi: 10.1093.
    PubMed     Abstract available


  281. CROUWEL F, Waaijenberg-Warmenhoven P, Buiter HJC, de Boer NK, et al
    Recurrent COVID-19 in a patient with ulcerative colitis on vedolizumab therapy.
    J Crohns Colitis. 2020 Dec 22. pii: 6044002. doi: 10.1093.
    PubMed    


  282. RAHMI G, Coron E, Perrod G, Levy M, et al
    Probe-based confocal laser endomicroscopy for in vivo assessment of histological healing in ulcerative colitis: development and validation of the ENHANCE index.
    J Crohns Colitis. 2020 Dec 18. pii: 6041240. doi: 10.1093.
    PubMed     Abstract available


  283. BANCIL AS, Sandall AM, Rossi M, Chassaing B, et al
    Food additive emulsifiers and their impact on gut microbiome, permeability and inflammation: mechanistic insights in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 18. pii: 6041235. doi: 10.1093.
    PubMed     Abstract available


  284. VENTIN-HOLMBERG R, Eberl A, Saqib S, Korpela K, et al
    Bacterial and fungal profiles as markers of infliximab drug response in inflammatory bowel disease.
    J Crohns Colitis. 2020 Dec 10. pii: 6029424. doi: 10.1093.
    PubMed     Abstract available


  285. VERMEIRE S, Su C, Lawendy N, Kobayashi T, et al
    Outcomes of Tofacitinib Dose Reduction in Patients with Ulcerative Colitis in Stable Remission from the Randomized RIVETING Trial.
    J Crohns Colitis. 2020 Dec 8. pii: 6027842. doi: 10.1093.
    PubMed     Abstract available


  286. MONSTAD IL, Solberg IC, Cvancarova M, Hovde O, et al
    Outcome of Ulcerative Colitis 20 Years after Diagnosis in a Prospective Population-based Inception Cohort from South-Eastern Norway, the IBSEN Study.
    J Crohns Colitis. 2020 Dec 2. pii: 6015889. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  287. JOHNSON LE, Lee MJ, Turner-Moore T, Grinsted Tate LR, et al
    Systematic review of factors affecting transition readiness skills in patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 30. pii: 6012510. doi: 10.1093.
    PubMed     Abstract available


  288. HAMAMA-RAZ Y, Nativ S, Hamama L
    Posttraumatic Growth in Inflammatory Bowel Disease Patients: The Role of Illness Cognitions and Physical Quality in Life.
    J Crohns Colitis. 2020 Nov 30. pii: 6012764. doi: 10.1093.
    PubMed     Abstract available


  289. TADBIRI S, Nachury M, Bouhnik Y, Serrero M, et al
    The IBD-disk is a reliable tool to assess the daily-life burden of patients with inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 27. pii: 6007776. doi: 10.1093.
    PubMed     Abstract available


  290. WINTHROP KL, Loftus EV Jr, Baumgart DC, Reinisch W, et al
    Tofacitinib for the Treatment of Ulcerative Colitis: Analysis of Infection Rates from the Ulcerative Colitis Clinical Programme.
    J Crohns Colitis. 2020 Nov 27. pii: 6007683. doi: 10.1093.
    PubMed     Abstract available


  291. VAN DEN BERGHE N, Verstockt B, Gils A, Sabino J, et al
    Tissue exposure does not explain non-response in ulcerative colitis patients with adequate serum vedolizumab concentrations.
    J Crohns Colitis. 2020 Nov 27. pii: 6007493. doi: 10.1093.
    PubMed     Abstract available


  292. EVERHOV AH, Bruze G, Soderling J, Askling J, et al
    Women's earnings are more affected by inflammatory bowel disease than men's: a register-based Swedish cohort study.
    J Crohns Colitis. 2020 Nov 27. pii: 6007494. doi: 10.1093.
    PubMed     Abstract available


  293. HOEKMAN DR, Vlieger AM, Stokkers PC, Mahhmod N, et al
    Hypnotherapy for irritable bowel syndrome-type symptoms in patients with quiescent inflammatory bowel disease: a randomized, controlled trial.
    J Crohns Colitis. 2020 Nov 27. pii: 6007495. doi: 10.1093.
    PubMed     Abstract available


  294. AGRAWAL M, Brenner EJ, Zhang X, Colombel JF, et al
    Physician practice patterns on holding inflammatory bowel disease medications due to COVID-19 in the SECURE-IBD registry.
    J Crohns Colitis. 2020 Nov 24. pii: 6000079. doi: 10.1093.
    PubMed     Abstract available


  295. TRAN-MINH ML, Gornet JM, Maillet M, Houze P, et al
    Safety of hydrocortisone premedication discontinuation in patients with inflammatory bowel disease on maintenance therapy with Infliximab: a prospective clinical and pharmacological study.
    J Crohns Colitis. 2020 Nov 18. pii: 5986749. doi: 10.1093.
    PubMed     Abstract available


  296. KALLA R, Adams AT, Bergemalm D, Vatn S, et al
    Serum proteomic profiling at diagnosis predicts clinical course, and need for intensification of treatment in inflammatory bowel disease.
    J Crohns Colitis. 2020 Nov 17. pii: 5985635. doi: 10.1093.
    PubMed     Abstract available


  297. GALLAGHER K, Catesson A, Griffin JL, Holmes E, et al
    Metabolomic Analysis in Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2020 Nov 11. pii: 5974408. doi: 10.1093.
    PubMed     Abstract available


  298. KIM MA, Kim YH, Chun J, Lee HS, et al
    The influence of disease activity on pregnancy outcomes in women with inflammatory bowel disease: A systematic review and meta-analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974276. doi: 10.1093.
    PubMed     Abstract available


  299. BARBERIO B, Black CJ, Savarino EV, Ford AC, et al
    Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    J Crohns Colitis. 2020 Nov 11. pii: 5974124. doi: 10.1093.
    PubMed     Abstract available


  300. SEBASTIAN S, Gonzalez HA, Peyrin-Biroulet L
    Safety of Drugs During Previous and Current Coronavirus Pandemics: Lessons for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14:1632-1643.
    PubMed     Abstract available


  301. TURSI A, Papa A
    Impact of Anti-TNFalpha Antibodies on the Risk of Covid-19 and its Severity in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:1646-1647.
    PubMed    


  302. VOSKUIL MD, Spekhorst LM, van der Sloot KWJ, Jansen BH, et al
    Genetic risk scores identify genetic aetiology of inflammatory bowel disease phenotypes.
    J Crohns Colitis. 2020 Nov 6. pii: 5957220. doi: 10.1093.
    PubMed     Abstract available


  303. YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
    Erratum to: Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients With Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    J Crohns Colitis. 2020 Nov 6. pii: 5958727. doi: 10.1093.
    PubMed    


    October 2020
  304. MAHMOUD R, van Lieshout C, Frederix GWJ, Jharap B, et al
    Continuation of anti-TNF in patients with Ulcerative Colitis in Remission is not Cost-effective compared to Treatment Withdrawal: a Markov Model.
    J Crohns Colitis. 2020 Oct 30. pii: 5944009. doi: 10.1093.
    PubMed     Abstract available


  305. SIEGEL CA, Christensen B, Kornbluth A, Rosh JR, et al
    Guidance for Restarting Inflammatory Bowel Disease Therapy in Patients Who Withheld Immunosuppressant Medications During COVID-19.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  306. LEWIN S, Lees C, Regueiro M, Hart A, et al
    International Organization for the Study of Inflammatory Bowel Disease: Global Strategies for Telemedicine and Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  307. DE LIMA-KARAGIANNIS A, Juillerat P, Sebastian S, Pedersen N, et al
    Management of Pregnant Inflammatory Bowel Disease Patients During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  308. ABREU MT, Peyrin-Biroulet L
    Providing Guidance During a Global Viral Pandemic for the Care of Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2020;14.
    PubMed    


  309. NG SC, Mak JWY, Hitz L, Chowers Y, et al
    COVID-19 Pandemic: Which IBD Patients Need to Be Scoped-Who Gets Scoped Now, Who Can Wait, and how to Resume to Normal.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  310. DOTAN I, Panaccione R, Kaplan GG, O'Morain C, et al
    Best Practice Guidance for Adult Infusion Centres during the COVID-19 Pandemic: Report from the COVID-19 International Organization for the Study of IBD [IOIBD] Task Force.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  311. ALLEZ M, Fleshner P, Gearry R, Lakatos PL, et al
    Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 Pandemic.
    J Crohns Colitis. 2020;14.
    PubMed     Abstract available


  312. QURAISHI MN, Iqbal TH, Hart AL
    Precision Medicine with FMT for Ulcerative Colitis: Are We There Yet?
    J Crohns Colitis. 2020 Oct 20. pii: 5932516. doi: 10.1093.
    PubMed    


  313. DERIKX LAAP, Lantinga MA, de Jong DJ, van Dop WA, et al
    Clinical Outcomes of Covid-19 in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    J Crohns Colitis. 2020 Oct 20. pii: 5932316. doi: 10.1093.
    PubMed     Abstract available


  314. BOSSUYT P, Bisschops R, Vermeire S, De Hertogh G, et al
    Variability in the distribution of histological disease activity in the colon of patients with ulcerative colitis.
    J Crohns Colitis. 2020 Oct 14. pii: 5923369. doi: 10.1093.
    PubMed     Abstract available


  315. ATTAUABI M, Poulsen A, Theede K, Pedersen N, et al
    Prevalence and outcomes of COVID-19 among patients with inflammatory bowel disease - A Danish prospective population-based cohort study.
    J Crohns Colitis. 2020 Oct 9. pii: 5920382. doi: 10.1093.
    PubMed     Abstract available


  316. ALOI M, Bramuzzo M, Norsa L, Arrigo S, et al
    Disease activity patterns in the first 5 years after diagnosis in children with ulcerative colitis: a population-based study.
    J Crohns Colitis. 2020 Oct 6. pii: 5918427. doi: 10.1093.
    PubMed     Abstract available


    September 2020
  317. MEREDITH J, Khedim CA, Henderson P, Wilson DC, et al
    Paediatric Inflammatory Multisystem Syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in a patient receiving Infliximab therapy for Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Sep 30. pii: 5913452. doi: 10.1093.
    PubMed     Abstract available


  318. ARHI C, Askari A, Nachiappan S, Bottle A, et al
    Stage at diagnosis and survival of colorectal cancer with or without underlying inflammatory bowel disease: a population-based study.
    J Crohns Colitis. 2020 Sep 29. pii: 5912977. doi: 10.1093.
    PubMed     Abstract available


  319. CHAPARRO M, Garre A, Mesonero F, Rodriguez C, et al
    Tofacitinib in Ulcerative Colitis: Real-world Evidence From the ENEIDA Registry.
    J Crohns Colitis. 2020 Sep 24. pii: 5910901. doi: 10.1093.
    PubMed     Abstract available


  320. MULLER M, Broseus J, Feugier P, Thieblemont C, et al
    Characteristics Of Lymphoma In Patients With Inflammatory Bowel Disease: A Systematic Review.
    J Crohns Colitis. 2020 Sep 19. pii: 5908884. doi: 10.1093.
    PubMed     Abstract available


  321. DRUVEFORS E, Landerholm K, Hammar U, Myrelid P, et al
    Impaired fertility in Women with Inflammatory Bowel Disease: A National Cohort Study from Sweden.
    J Crohns Colitis. 2020 Sep 19. pii: 5908862. doi: 10.1093.
    PubMed     Abstract available


  322. VENY M, Garrido-Trigo A, Corraliza AM, Masamunt MC, et al
    Dissecting common and unique effects of anti-alpha4beta7 and anti-tumor necrosis factor treatment in ulcerative colitis.
    J Crohns Colitis. 2020 Sep 14. pii: 5905252. doi: 10.1093.
    PubMed     Abstract available


  323. MERLI AM, Vieujean S, Massot C, Bletard N, et al
    Solute carrier family 12 member 2 as a proteomic and histological biomarker of dysplasia and neoplasia in ulcerative colitis.
    J Crohns Colitis. 2020 Sep 13. pii: 5905032. doi: 10.1093.
    PubMed     Abstract available


  324. CONLEY TE, Probert C, Subramanian S
    Prevalence of COVID-19 Symptoms among Inflammatory Bowel Disease Patients Treated with Biological Agents.
    J Crohns Colitis. 2020 Sep 11. pii: 5904432. doi: 10.1093.
    PubMed    


  325. JANGI S, Holmer AK, Dulai PS, Boland BS, et al
    Risk of Relapse in Patients with Ulcerative Colitis with Persistent Endoscopic Healing: A Durable Treatment Endpoint.
    J Crohns Colitis. 2020 Sep 10. pii: 5903914. doi: 10.1093.
    PubMed     Abstract available


  326. MAK JWY, Ho CLT, Wong K, Cheng TY, et al
    Epidemiology and Natural History of Elderly-onset inflammatory bowel disease: Results from a territory-wide Hong Kong IBD registry.
    J Crohns Colitis. 2020 Sep 10. pii: 5903917. doi: 10.1093.
    PubMed     Abstract available


  327. VALTER M, Verstockt S, Finalet Ferreiro JA, Cleynen I, et al
    Extracellular vesicles in inflammatory bowel disease: small particles, big players.
    J Crohns Colitis. 2020 Sep 9. pii: 5903363. doi: 10.1093.
    PubMed     Abstract available


  328. WASMANN KA, van der Does de Willebois EM, Koens L, Duijvestein M, et al
    The Impact of Rectal Stump Inflammation After Subtotal Colectomy on Pouch Outcomes in Ulcerative Colitis Patients.
    J Crohns Colitis. 2020 Sep 9. pii: 5903251. doi: 10.1093.
    PubMed     Abstract available


  329. MAGRO F, Estevinho MM, Dias CC, Correia L, et al
    Clinical, endoscopic and histological outcomes in induction of moderate-to-severe ulcerative colitis: a systematic review with meta-analysis.
    J Crohns Colitis. 2020 Sep 8. pii: 5902904. doi: 10.1093.
    PubMed     Abstract available


  330. MAGRO F, Estevinho MM
    Newborn Congenital Abnormalities and Inflammatory Bowel Disease: Unveiling an Unexplored Relationship.
    J Crohns Colitis. 2020;14:1033-1034.
    PubMed    


    August 2020
  331. CAMILLERI M
    Ten Reasons to Think about Bile Acids in Managing Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Aug 31. pii: 5899784. doi: 10.1093.
    PubMed    


  332. MATSUOKA K, Igarashi A, Sato N, Isono Y, et al
    Trends in corticosteroid prescriptions for ulcerative colitis and factors associated with long-term corticosteroid use: analysis using Japanese claims data from 2006 to 2016.
    J Crohns Colitis. 2020 Aug 26. pii: 5897347. doi: 10.1093.
    PubMed     Abstract available


  333. OLESEN SW, Gerardin Y
    Re-evaluating the evidence for fecal microbiota transplantation "super-donors" in inflammatory bowel disease.
    J Crohns Colitis. 2020 Aug 18. pii: 5893677. doi: 10.1093.
    PubMed     Abstract available


  334. SOOD A, Singh A, Mahajan R, Midha V, et al
    Clinical Predictors of response to Faecal Microbiota Transplantation in patients with active ulcerative colitis.
    J Crohns Colitis. 2020 Aug 9. pii: 5890140. doi: 10.1093.
    PubMed     Abstract available


  335. REINISCH W, Danese S, Peyrin-Biroulet L, Loftus EV, et al
    Clinical Trials for Inflammatory Bowel Disease: Global Guidance During the COVID-19 Pandemic.
    J Crohns Colitis. 2020 Aug 7. pii: 5885159. doi: 10.1093.
    PubMed    


    July 2020
  336. GHOSH S, Sensky T, Casellas F, Rioux LC, et al
    A Global, Prospective, Observational Study Measuring Disease Burden and Suffering in Patients with Ulcerative Colitis Using the Pictorial Representation of Illness and Self-Measure Tool.
    J Crohns Colitis. 2020 Jul 29. pii: 5877457. doi: 10.1093.
    PubMed     Abstract available


  337. MAGRO F, Rahier JF, Abeu C, MacMahon E, et al
    Inflammatory bowel disease management during the COVID-19 outbreak: The 10 do's and don'ts from the ECCO-COVID Taskforce.
    J Crohns Colitis. 2020 Jul 29. pii: 5877458. doi: 10.1093.
    PubMed     Abstract available


  338. MANTA R, Zullo A, Telesca A, Castellani D, et al
    Endoscopic Submucosal Dissection for visible dysplasia treatment in ulcerative colitis patients: cases series and systematic review of literature.
    J Crohns Colitis. 2020 Jul 25. pii: 5876412. doi: 10.1093.
    PubMed     Abstract available


  339. FUMERY M, Matias C, Brochot E
    Seroconversion of immunoglobulins to SARS-CoV2 in patients with inflammatory bowel disease patients treated by biologics.
    J Crohns Colitis. 2020 Jul 22. pii: 5875101. doi: 10.1093.
    PubMed    


  340. PRIVITERA G, Onali S, Pugliese D, Renna S, et al
    Dual Targeted Therapy: a possible option for the management of refractory Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 17. pii: 5872608. doi: 10.1093.
    PubMed     Abstract available


  341. ALLOCCA M, Furfaro F, Fiorino G, Peyrin-Biroulet L, et al
    Point-of-care ultrasound in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 17. pii: 5872609. doi: 10.1093.
    PubMed     Abstract available


  342. BLACKWELL J, Saxena S, Jayasooriya N, Bottle A, et al
    Prevalence and duration of gastrointestinal symptoms before diagnosis of Inflammatory Bowel Disease and predictors of timely specialist review: a population-based study.
    J Crohns Colitis. 2020 Jul 15. pii: 5871943. doi: 10.1093.
    PubMed     Abstract available


  343. CROUWEL F, Buiter HJC, de Boer NK
    Gut microbiota-driven drug metabolism in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jul 11. pii: 5870328. doi: 10.1093.
    PubMed     Abstract available


  344. TARGOWNIK LE, Benchimol EI, Bernstein CN, Singh H, et al
    Combined Biologic and Immunomodulatory Therapy is Superior to Monotherapy for Decreasing the Risk of Inflammatory Bowel Disease-Related Complications.
    J Crohns Colitis. 2020 Jul 10. pii: 5869652. doi: 10.1093.
    PubMed     Abstract available


  345. MARGALIT-YEHUDA R, Ben-Horin S
    Bottom-up: Can Trans-anal Rectal Resection Improve Outcomes in Ulcerative Colitis Patients Undergoing Proctocolectomy and Ileo-anal Pouch Anastomosis?
    J Crohns Colitis. 2020;14:724-725.
    PubMed    


  346. PARRA RS, Feitosa MR, Feres O
    Segmental Colectomy: An Alternative for Ulcerative Colitis in Endoscopic Remission?
    J Crohns Colitis. 2020 Jul 6. pii: 5868033. doi: 10.1093.
    PubMed    


  347. GOODSALL TM, Nguyen TM, Parker CE, Ma C, et al
    Systematic review: Gastrointestinal ultrasound scoring indices for inflammatory bowel disease.
    J Crohns Colitis. 2020 Jul 2. pii: 5866421. doi: 10.1093.
    PubMed     Abstract available


  348. SULTAN K, Swaminath A
    From Bad to Worse: The Relationship Between Opioid Use and Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jul 2. pii: 5866377. doi: 10.1093.
    PubMed    


    June 2020
  349. TSENG CH
    Metformin use is associated with a lower risk of inflammatory bowel disease in patients with type 2 diabetes mellitus.
    J Crohns Colitis. 2020 Jun 30. pii: 5865444. doi: 10.1093.
    PubMed     Abstract available


  350. GOODSALL TM, Costello SP, Bryant RV
    Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough.
    J Crohns Colitis. 2020 Jun 30. pii: 5865087. doi: 10.1093.
    PubMed    


  351. ZHOU M, He J, Shi Y, Liu X, et al
    ABIN3 negatively regulates necroptosis-induced intestinal inflammation through recruiting A20 and restricting the ubiquitination of RIPK3 in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 30. pii: 5864883. doi: 10.1093.
    PubMed     Abstract available


  352. KALLA R, Adams AT, Ventham NT, Kennedy NA, et al
    Whole blood profiling of T-cell derived miRNA allows the development of prognostic models in inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 29. pii: 5864785. doi: 10.1093.
    PubMed     Abstract available


  353. SCHREINER P, Mueller NJ, Fehr J, Maillard MH, et al
    Varicella zoster virus in inflammatory bowel disease patients: what every gastroenterologist should know.
    J Crohns Colitis. 2020 Jun 27. pii: 5864104. doi: 10.1093.
    PubMed     Abstract available


  354. LIGHTNER AL, Vogler S, McMichael J, Jia X, et al
    Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's disease.
    J Crohns Colitis. 2020 Jun 27. pii: 5864008. doi: 10.1093.
    PubMed     Abstract available


  355. SCHREIBER S, Dignass A, Rogge A, Rubin DT, et al
    Stopping Clinical Trials in Inflammatory Bowel Disease During the COVID-19 Pandemic is not a Responsible Act.
    J Crohns Colitis. 2020 Jun 25. pii: 5862397. doi: 10.1093.
    PubMed     Abstract available


  356. D'AMICO F, Peyrin-Biroulet L, Danese S
    JAK or GUT Selectivity: Tipping the Balance for Efficacy and Safety in Ulcerative Colitis.
    J Crohns Colitis. 2020 Jun 24. pii: 5862030. doi: 10.1093.
    PubMed    


  357. MUKHERJEE S, Beresford B, Atkin K, Sebastian S, et al
    The need for culturally competent care within gastroenterology services: Evidence from research with adults of South Asian origin living with inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 23. pii: 5861668. doi: 10.1093.
    PubMed     Abstract available


  358. VAN DER SLOOT KWJ, Weersma RK, Alizadeh BZ, Dijkstra G, et al
    Identification of environmental risk factors associated with the development of Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Jun 23. pii: 5861037. doi: 10.1093.
    PubMed     Abstract available


  359. GRUNERT PC, Reuken PA, Stallhofer J, Teich N, et al
    Inflammatory Bowel Disease in the COVID-19 Pandemic - the Patients' Perspective.
    J Crohns Colitis. 2020 Jun 20. pii: 5860461. doi: 10.1093.
    PubMed     Abstract available


  360. D'AMICO F, Baumann C, Rousseau H, Danese S, et al
    Phase I, II and III Trials in Inflammatory Bowel Diseases: A Practical Guide for the Non-specialist.
    J Crohns Colitis. 2020;14:710-718.
    PubMed     Abstract available


  361. SOMERS M, Bossuyt P, Ferrante M, Peeters H, et al
    Belgian IBD Research Group [BIRD] Position Statement 2019 on the Use of Adalimumab Biosimilars in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:680-685.
    PubMed     Abstract available


  362. VON MARTELS JZH, Bourgonje AR, Klaassen MAY, Alkhalifah HAA, et al
    Riboflavin Supplementation in Patients with Crohn's Disease [the RISE-UP study].
    J Crohns Colitis. 2020;14:595-607.
    PubMed     Abstract available


  363. FAUNY M, D'Amico F, Bonovas S, Netter P, et al
    Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
    J Crohns Colitis. 2020;14:688-693.
    PubMed     Abstract available


  364. ZHOU C, Wu XR, Liu HS, Liu XH, et al
    Immunomodulatory Effect of Urine-derived Stem Cells on Inflammatory Bowel Diseases via Downregulating Th1/Th17 Immune Responses in a PGE2-dependent Manner.
    J Crohns Colitis. 2020;14:654-668.
    PubMed     Abstract available


  365. VALE RODRIGUES R, Sladek M, Katsanos K, van der Woude CJ, et al
    Diagnosis and Outcome of Oesophageal Crohn's Disease.
    J Crohns Colitis. 2020;14:624-629.
    PubMed     Abstract available


  366. AL NABHANI Z, Berrebi D, Martinez-Vinson C, Montcuquet N, et al
    Nod2 Protects the Gut From Experimental Colitis Spreading to Small Intestine.
    J Crohns Colitis. 2020;14:669-679.
    PubMed     Abstract available


  367. ZHAO M, Burisch J
    The Sooner the Better? Cost-effectiveness of Early Biological Therapy in Patients With Crohn's Disease.
    J Crohns Colitis. 2020;14:573-574.
    PubMed    


  368. EDER P, Dobrowolska A, Rydzewska G
    Historical Upheavals and Eponyms in Crohn's Disease-Is There Any Relation?
    J Crohns Colitis. 2020;14:719.
    PubMed    


  369. WEISSMAN S, Goldowsky A, Mehta TI, Sciarra MA, et al
    Are Quality Metrics in Inflammatory Bowel Disease Rooted on Substantial Quality Evidence? A Systematic Review.
    J Crohns Colitis. 2020 Jun 16. pii: 5858213. doi: 10.1093.
    PubMed     Abstract available


  370. REINISCH W, Danese S, Peyrin-Biroulet L, Loftus EV, et al
    Clinical trials for inflammatory bowel disease: a global guidance during COVID-19 pandemic.
    J Crohns Colitis. 2020 Jun 10. pii: 5855532. doi: 10.1093.
    PubMed     Abstract available


  371. MAGRO F, Doherty G, Peyrin-Biroulet L, Svrcek M, et al
    ECCO Position Paper: Harmonisation of the approach to Ulcerative Colitis Histopathology.
    J Crohns Colitis. 2020 Jun 6. pii: 5854301. doi: 10.1093.
    PubMed     Abstract available


  372. FRONTALI A, Cohen L, Bridoux V, Myrelid P, et al
    Segmental colectomy for ulcerative colitis: is there a place in selected patients without active colitis ? An international multicentric retrospective study in 72 patients.
    J Crohns Colitis. 2020 Jun 4. pii: 5851522. doi: 10.1093.
    PubMed     Abstract available


  373. FRIEDMAN S, Nielsen J, Jolving LR, Nohr EA, et al
    Long-term motor and cognitive function in the children of women with inflammatory bowel disease.
    J Crohns Colitis. 2020 Jun 4. pii: 5851419. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  374. NEHRA AK, Sheedy SP, Wells ML, VanBuren WM, et al
    Imaging Findings of Ileal Inflammation at Computed Tomography and Magnetic Resonance Enterography: What do They Mean When Ileoscopy and Biopsy are Negative?
    J Crohns Colitis. 2020;14:455-464.
    PubMed     Abstract available


  375. DANIELOU M, Sarter H, Pariente B, Fumery M, et al
    Natural History of Perianal Fistulising Lesions in Patients With Elderly-onset Crohn's Disease: A Population-based Study.
    J Crohns Colitis. 2020;14:501-507.
    PubMed     Abstract available


  376. PILLAI N, Lupatsch JE, Dusheiko M, Schwenkglenks M, et al
    Evaluating the Cost-Effectiveness of Early Compared with Late or No Biologic Treatment to Manage Crohn's Disease using Real-World Data.
    J Crohns Colitis. 2020;14:490-500.
    PubMed     Abstract available


  377. CONDAMINA M, Diaz E, Jamart C, Loget J, et al
    Severe Attack of Henoch-Schonlein Purpura With Neurological Involvement During Adalimumab Treatment for Crohn's Disease.
    J Crohns Colitis. 2020;14:538-542.
    PubMed     Abstract available


  378. SPARROW MP, Papamichael K, Ward MG, Riviere P, et al
    Therapeutic Drug Monitoring of Biologics During Induction to Prevent Primary Non-Response.
    J Crohns Colitis. 2020;14:542-556.
    PubMed     Abstract available


  379. RODRIGUEZ-LAGO I, Gisbert JP
    The Role of Immunomodulators and Biologics in the Medical Management of Stricturing Crohn's Disease.
    J Crohns Colitis. 2020;14:557-566.
    PubMed     Abstract available


  380. DHALIWAL J, Walters TD, Mack DR, Huynh HQ, et al
    Phenotypic Variation in Paediatric Inflammatory Bowel Disease by Age: A Multicentre Prospective Inception Cohort Study of the Canadian Children IBD Network.
    J Crohns Colitis. 2020;14:445-454.
    PubMed     Abstract available


  381. MADARAME A, Kimura H, Kunisaki R
    Successful Treatment With Ustekinumab for Enterocutaneous Fistulas in Crohn's Disease.
    J Crohns Colitis. 2020;14:569-570.
    PubMed    


  382. CHATEAU T, Angioi K, Peyrin-Biroulet L
    Two Cases of Successful Ustekinumab Treatment for Non-infectious Uveitis Associated With Crohn's Disease.
    J Crohns Colitis. 2020;14:571.
    PubMed    


  383. PARK SH, Kim HJ, Lee CK, Song EM, et al
    Safety and optimal timing of BCG vaccination in infants born to mothers receiving anti-TNF therapy for inflammatory bowel disease.
    J Crohns Colitis. 2020 May 17. pii: 5838422. doi: 10.1093.
    PubMed     Abstract available


  384. VARIOLA A, Zanolin E, Cipriano G, Macchioni P, et al
    The IBIS-Q (IBd Identification of Spondyloarthrytis Questionnaire): a novel tool to detect both Axial and Peripheral Arthritis in Inflammatory Bowel Disease patients.
    J Crohns Colitis. 2020 May 15. pii: 5837772. doi: 10.1093.
    PubMed     Abstract available


  385. LIANG G, Conrad MA, Kelsen JR, Kessler LR, et al
    The dynamics of the stool virome in very early onset inflammatory bowel disease.
    J Crohns Colitis. 2020 May 14. pii: 5837025. doi: 10.1093.
    PubMed     Abstract available


  386. CHAPMAN S, Sibelli A, St-Clair Jones A, Forbes A, et al
    Personalised Adherence Support for Maintenance Treatment of Inflammatory Bowel Disease: A Tailored Digital Intervention to Change Adherence-related Beliefs and Barriers.
    J Crohns Colitis. 2020 May 7. pii: 5831700. doi: 10.1093.
    PubMed     Abstract available


  387. HORIO Y, Uchino M, Bando T, Sasaki H, et al
    Incidence, Risk Factors, and Outcomes of Cancer of the Anal Transitional Zone with Ulcerative Colitis..
    J Crohns Colitis. 2020 May 4. pii: 5828994. doi: 10.1093.
    PubMed     Abstract available


    April 2020
  388. BOIVINEAU L, Le Mehaute A, Roblin X
    Prospective evaluation of cytomegalovirus time-course kinetics in colonic biopsies from patients with moderate-to-severe ulcerative colitis following infliximab treatment: a prospective study.
    J Crohns Colitis. 2020 Apr 28. pii: 5826392. doi: 10.1093.
    PubMed    


  389. FLANAGAN E, Wright EK, Begun J, Bryant RV, et al
    Monitoring Inflammatory Bowel Disease in Pregnancy using Gastrointestinal Ultrasonography.
    J Crohns Colitis. 2020 Apr 28. pii: 5826347. doi: 10.1093.
    PubMed     Abstract available


  390. ZHANG B, Gulati A, Alipour O, Shao L, et al
    Relapse from deep remission after therapeutic de-escalation in inflammatory bowel disease: a systematic review and meta-analysis.
    J Crohns Colitis. 2020 Apr 26. pii: 5825450. doi: 10.1093.
    PubMed     Abstract available


  391. PHILLIPS FM, Verstockt B, Sebastian S, Ribaldone DG, et al
    Inflammatory cutaneous lesions in inflammatory bowel disease treated with Vedolizumab or Ustekinumab: an ECCO CONFER multicentre case series.
    J Crohns Colitis. 2020 Apr 22. pii: 5823596. doi: 10.1093.
    PubMed     Abstract available


  392. PEYRIN-BIROULET C, D'Amico F, Peyrin-Biroulet L
    Will COVID-19 infection be less severe in ulcerative colitis than in Crohn's patients due to a lower rate of smokers?
    J Crohns Colitis. 2020 Apr 18. pii: 5821493. doi: 10.1093.
    PubMed    


  393. HONAP S, Chee D, Chapman TP, Patel M, et al
    Real-World Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multi-Centre UK Experience.
    J Crohns Colitis. 2020 Apr 13. pii: 5819381. doi: 10.1093.
    PubMed     Abstract available


  394. CARDINALE CJ, March ME, Lin X, Liu Y, et al
    Regulation of Janus Kinase 2 by an Inflammatory Bowel Disease Causal Non-coding Single Nucleotide Polymorphism.
    J Crohns Colitis. 2020 Apr 9. pii: 5818372. doi: 10.1093.
    PubMed     Abstract available


  395. CHRISTENSEN B, Hanauer SB, Gibson PR, Turner JR, et al
    Segmental Histologic Normalisation Occurs in Ulcerative Colitis but does not Improve Clinical Outcomes.
    J Crohns Colitis. 2020 Apr 8. pii: 5817864. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  396. BAI X, Yang H, Qian J
    COVID-19 outbreak and inflammatory bowel disease management: a questionnaire survey from realistic practice.
    J Crohns Colitis. 2020 Mar 28. pii: 5812999. doi: 10.1093.
    PubMed    


  397. MONTELEONE G, Ardizzone S
    Are patients with inflammatory bowel disease at increased risk for Covid-19 infection?
    J Crohns Colitis. 2020 Mar 26. pii: 5811674. doi: 10.1093.
    PubMed     Abstract available


  398. VAN ANDEL EM, Koopmann BDM, Crouwel F, Noomen CG, et al
    Systematic review of development and content validity of patient-reported outcome measures in Inflammatory Bowel Disease: do we measure what we measure?
    J Crohns Colitis. 2020 Mar 25. pii: 5811405. doi: 10.1093.
    PubMed     Abstract available


  399. FIORINO G, Allocca M, Furfaro F, Gilardi D, et al
    Inflammatory bowel disease care in the COVID-19 pandemic era: the Humanitas, Milan experience.
    J Crohns Colitis. 2020 Mar 24. pii: 5811431. doi: 10.1093.
    PubMed     Abstract available


  400. CALAFAT M, Manosa M, Mesonero F, Guardiola J, et al
    Switching to a second thiopurine in adult and elderly patients with inflammatory bowel disease: a nationwide study from the ENEIDA registry.
    J Crohns Colitis. 2020 Mar 23. pii: 5810964. doi: 10.1093.
    PubMed     Abstract available


  401. IACUCCI M, Cannatelli R, Gui XS, Zardo D, et al
    Assessment of endoscopic healing by using advanced technologies reflects histologic healing in ulcerative colitis.
    J Crohns Colitis. 2020 Mar 23. pii: 5810912. doi: 10.1093.
    PubMed     Abstract available


  402. SCHREIBER S, Hanauer SB, Sandborn WJ, Barrett K, et al
    Time to Symptom Resolution in Ulcerative Colitis With Multimatrix Mesalazine Treatment: A Pooled Analysis.
    J Crohns Colitis. 2020 Mar 17. pii: 5807996. doi: 10.1093.
    PubMed     Abstract available


  403. SLEVIN SM, Garner LC, Lahiff C, Tan M, et al
    Lymphocyte activation gene (LAG)-3 is associated with mucosal inflammation and disease activity in ulcerative colitis.
    J Crohns Colitis. 2020 Mar 16. pii: 5807948. doi: 10.1093.
    PubMed     Abstract available


  404. DORRINGTON AM, Selinger CP, Parkes GC, Smith M, et al
    The historical role and contemporary use of corticosteroids in inflammatory bowel disease.
    J Crohns Colitis. 2020 Mar 14. pii: 5805149. doi: 10.1093.
    PubMed     Abstract available


  405. BARTKO J, Reichardt B, Kocijan R, Klaushofer K, et al
    Inflammatory Bowel Disease: A Nationwide Study of Hip Fracture and Mortality Risk after Hip Fracture.
    J Crohns Colitis. 2020 Mar 14. pii: 5805150. doi: 10.1093.
    PubMed     Abstract available



  406. Retraction: An interim analysis of real-world safety data from an ongoing, non-interventional, observational study of patients with inflammatory bowel disease treated with CT-P13, an infliximab biosimilar, in the context of usual care with reference i
    J Crohns Colitis. 2020;14:428.
    PubMed    


  407. YOKOYAMA Y, Sawada K, Aoyama N, Yoshimura N, et al
    Efficacy of Granulocyte and Monocyte Adsorptive Apheresis in Patients with Inflammatory Bowel Disease Showing Lost Response to Infliximab.
    J Crohns Colitis. 2020 Mar 13. pii: 5804700. doi: 10.1093.
    PubMed     Abstract available


  408. ANNESE V
    Small Bowel Adenocarcinoma in Crohn's Disease: An Underestimated Risk?
    J Crohns Colitis. 2020;14:285-286.
    PubMed    


  409. CARBONNEL F, Svrcek M
    Progress in the Molecular and Histological Dissection of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:283-284.
    PubMed    


  410. DELATTRE C, Lewis A, Kirchgesner J, Nion-Larmurier I, et al
    Impact of Aphthous Colitis at Diagnosis on Crohn's Disease Outcomes.
    J Crohns Colitis. 2020;14:342-350.
    PubMed     Abstract available


  411. FELWICK RK, Dingley GJR, Martinez-Nunez R, Sanchez-Elsner T, et al
    MicroRNA23a Overexpression in Crohn's Disease Targets Tumour Necrosis Factor Alpha Inhibitor Protein 3, Increasing Sensitivity to TNF and Modifying the Epithelial Barrier.
    J Crohns Colitis. 2020;14:381-392.
    PubMed     Abstract available


  412. FIELDS AC, Hu FY, Lu P, Irani J, et al
    Small Bowel Adenocarcinoma: Is There a Difference in Survival for Crohn's Versus Sporadic Cases?
    J Crohns Colitis. 2020;14:303-308.
    PubMed     Abstract available


  413. BORREN NZ, Tan W, Colizzo FP, Luther J, et al
    Longitudinal Trajectory of Fatigue With Initiation of Biologic Therapy in Inflammatory Bowel Diseases: A Prospective Cohort Study.
    J Crohns Colitis. 2020;14:309-315.
    PubMed     Abstract available


  414. PIOVANI D, Danese S, Peyrin-Biroulet L, Bonovas S, et al
    Environmental, Nutritional, and Socioeconomic Determinants of IBD Incidence: A Global Ecological Study.
    J Crohns Colitis. 2020;14:323-331.
    PubMed     Abstract available


  415. FRANZE E, Monteleone I, Laudisi F, Rizzo A, et al
    Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    J Crohns Colitis. 2020;14:406-417.
    PubMed     Abstract available


  416. VERSTOCKT B, Mertens E, Dreesen E, Outtier A, et al
    Influence of Drug Exposure on Vedolizumab-Induced Endoscopic Remission in Anti-Tumour Necrosis Factor [TNF] Naive and Anti-TNF Exposed IBD Patients.
    J Crohns Colitis. 2020;14:332-341.
    PubMed     Abstract available


  417. POREDSKA K, Kunovsky L, Marek F, Kala Z, et al
    The Influence of Microscopic Inflammation at Resection Margins on Early Postoperative Endoscopic Recurrence After Ileocaecal Resection for Crohn's Disease.
    J Crohns Colitis. 2020;14:361-368.
    PubMed     Abstract available


  418. ARPA G, Grillo F, Giuffrida P, Nesi G, et al
    Separation of Low- Versus High-grade Crohn's Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis.
    J Crohns Colitis. 2020;14:295-302.
    PubMed     Abstract available


  419. PELLINO G, Vinci D, Signoriello G, Kontovounisios C, et al
    Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
    J Crohns Colitis. 2020;14:418-427.
    PubMed     Abstract available


  420. LIAO X, Li G, McBride R, Houldsworth J, et al
    Clinicopathological and Molecular Characterisation of Crohn's Disease-associated Small Bowel Adenocarcinomas.
    J Crohns Colitis. 2020;14:287-294.
    PubMed     Abstract available


  421. SANDBORN WJ, Nguyen DD, Beattie DT, Brassil P, et al
    Development of gut-selective pan-Janus kinase inhibitor TD-1473 for ulcerative colitis: A translational medicine program.
    J Crohns Colitis. 2020 Mar 11. pii: 5803305. doi: 10.1093.
    PubMed     Abstract available


  422. SEVERYNS T, Kirchgesner J, Lambert J, Thieblemont C, et al
    Prognosis of lymphoma in patients with known Inflammatory Bowel Disease: a French multicentre cohort study.
    J Crohns Colitis. 2020 Mar 11. pii: 5803309. doi: 10.1093.
    PubMed     Abstract available


  423. BARNHOORN MC, Hakuno SK, Bruckner RS, Rogler G, et al
    Stromal Cells in the Pathogenesis of Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Mar 11. pii: 5803221. doi: 10.1093.
    PubMed     Abstract available


  424. LEFEVRE PLC, Vande Casteele N
    Clinical Pharmacology of Janus Kinase Inhibitors in Inflammatory Bowel Disease.
    J Crohns Colitis. 2020 Mar 11. pii: 5803222. doi: 10.1093.
    PubMed     Abstract available


  425. LAUBE R, Yau Y, Selinger CP, Seow CH, et al
    Knowledge and attitudes towards pregnancy in females with Inflammatory Bowel Disease - an international, multi-centre study.
    J Crohns Colitis. 2020 Mar 11. pii: 5803333. doi: 10.1093.
    PubMed     Abstract available


  426. SHAH SC, Itzkowitz SH
    Reappraising risk factors for inflammatory bowel disease-associated neoplasia: Implications for colonoscopic surveillance in IBD.
    J Crohns Colitis. 2020 Mar 9. pii: 5801093. doi: 10.1093.
    PubMed     Abstract available


    February 2020
  427. ROBERTS SE, Thorne K, Thapar N, Broekaert I, et al
    A systematic review and meta analysis of paediatric inflammatory bowel disease incidence and prevalence across Europe.
    J Crohns Colitis. 2020 Feb 28. pii: 5770946. doi: 10.1093.
    PubMed     Abstract available


  428. NOHR EA, Nielsen J, Norgard BM, Friedman S, et al
    Sexual health in women with inflammatory bowel disease in the Danish National Birth Cohort.
    J Crohns Colitis. 2020 Feb 27. pii: 5760869. doi: 10.1093.
    PubMed     Abstract available


  429. MOURAD FH, Hashash JG, Kariyawasam VC, Leong RW, et al
    Ulcerative Colitis and Cytomegalovirus Infection: From A to Z.
    J Crohns Colitis. 2020 Feb 27. pii: 5760718. doi: 10.1093.
    PubMed     Abstract available


  430. SOLA TAPIAS N, Vergnolle N, Denadai-Souza A, Barreau F, et al
    The interplay between genetic risk factors and proteolytic dysregulation in the pathophysiology of inflammatory bowel disease.
    J Crohns Colitis. 2020 Feb 22. pii: 5748295. doi: 10.1093.
    PubMed     Abstract available


  431. MEUNIER L, Clerc C, Meszaros M
    Use of Tofacitinib for ulcerative colitis in a liver transplant patient.
    J Crohns Colitis. 2020 Feb 19. pii: 5740228. doi: 10.1093.
    PubMed    


  432. SHAH R, Hoffman GR, El-Dallal M, Goldowsky AM, et al
    Is Therapeutic Drug Monitoring for Anti-Tumor Necrosis Factor Agents in Adults with Inflammatory Bowel Disease Ready for Standard of Care?: A Systematic Review and Meta-analysis.
    J Crohns Colitis. 2020 Feb 17. pii: 5736596. doi: 10.1093.
    PubMed     Abstract available


  433. VERMEIRE S, Lukas M, Magro F, Adsul S, et al
    Vedolizumab Efficacy, Safety, and Pharmacokinetics with Reduced Frequency of Dosing From Every 4 Weeks to Every 8 Weeks in Patients with Crohn's Disease or Ulcerative Colitis.
    J Crohns Colitis. 2020 Feb 15. pii: 5736390. doi: 10.1093.
    PubMed     Abstract available


  434. ZADRO V, Santus P, Maconi G
    Ulcerative Colitis: not only gut.
    J Crohns Colitis. 2020 Feb 14. pii: 5735761. doi: 10.1093.
    PubMed    


  435. SCHREIBER S
    Lack of Efficacy in Crohn's Disease Prompts Unplanned Interim Analysis and Termination of Study in Ulcerative Colitis.
    J Crohns Colitis. 2020;14:282.
    PubMed    


  436. SIEGMUND B
    Are Serum-Based Markers Going to Replace Faecal Neutrophil Markers in Ulcerative Colitis?
    J Crohns Colitis. 2020;14:151-152.
    PubMed    


  437. ADAMINA M, Bonovas S, Raine T, Spinelli A, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Surgical Treatment.
    J Crohns Colitis. 2020;14:155-168.
    PubMed     Abstract available


  438. MAGRO F, Lopes J, Borralho P, Lopes S, et al
    Comparing the Continuous Geboes Score With the Robarts Histopathology Index: Definitions of Histological Remission and Response and their Relation to Faecal Calprotectin Levels.
    J Crohns Colitis. 2020;14:169-175.
    PubMed     Abstract available


  439. WASMANN KA
    Complications While Waiting for IBD Surgery-Short Report.
    J Crohns Colitis. 2020;14:277-280.
    PubMed     Abstract available


  440. KEITA AV, Alkaissi LY, Holm EB, Heil SDS, et al
    Enhanced E. coli LF82 Translocation through the Follicle-associated Epithelium in Crohn's Disease is Dependent on Long Polar Fimbriae and CEACAM6 expression, and Increases Paracellular Permeability.
    J Crohns Colitis. 2020;14:216-229.
    PubMed     Abstract available


  441. AGRAWAL M, Burisch J, Colombel JF, C Shah S, et al
    Viewpoint: Inflammatory Bowel Diseases Among Immigrants From Low- to High-Incidence Countries: Opportunities and Considerations.
    J Crohns Colitis. 2020;14:267-273.
    PubMed     Abstract available


  442. PIERRE N, Salee C, Massot C, Bletard N, et al
    Proteomics Highlights Common and Distinct Pathophysiological Processes Associated with Ileal and Colonic Ulcers in Crohn's Disease.
    J Crohns Colitis. 2020;14:205-215.
    PubMed     Abstract available


  443. COSTA-MOREIRA P, Lopes S, Santos AL, Pedrosa AF, et al
    Leukocytoclastic Vasculitis Related to Ustekinumab in a Crohn's Disease Patient: First Case Report and Literature Review.
    J Crohns Colitis. 2020;14:274-276.
    PubMed     Abstract available


  444. KOTWANI P, Terdiman J, Lewin S
    Tofacitinib for rescue therapy in acute severe ulcerative colitis: a real-world experience.
    J Crohns Colitis. 2020 Feb 5. pii: 5727212. doi: 10.1093.
    PubMed     Abstract available


  445. OSTVIK AE, Svendsen TD, Granlund AVB, Doseth B, et al
    Intestinal epithelial cells express immunomodulatory ISG15 during active ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2020 Feb 5. pii: 5727513. doi: 10.1093.
    PubMed     Abstract available


  446. LO B, Holm JP, Vester-Andersen MK, Bendtsen F, et al
    Incidence, risk factors and evaluation of osteoporosis in patients with inflammatory bowel disease - a Danish population-based inception cohort with 10 years of follow-up.
    J Crohns Colitis. 2020 Feb 4. pii: 5722012. doi: 10.1093.
    PubMed     Abstract available


  447. QURAISHI MN, Acharjee A, Beggs AD, Horniblow R, et al
    A pilot integrative analysis of colonic gene expression, gut microbiota and immune infiltration in primary sclerosing cholangitis-inflammatory bowel disease: association of disease with bile acid pathways.
    J Crohns Colitis. 2020 Feb 4. pii: 5722016. doi: 10.1093.
    PubMed     Abstract available


  448. AGRAWAL M, Kim ES, Colombel JF
    JAK inhibitors safety in ulcerative colitis: practical implications.
    J Crohns Colitis. 2020 Feb 1. pii: 5719575. doi: 10.1093.
    PubMed     Abstract available


    January 2020
  449. DE JONG ME, Smits LJT, van Ruijven B, den Broeder N, et al
    Increased discontinuation rates of anti-TNF therapy in elderly inflammatory bowel disease patients.
    J Crohns Colitis. 2020 Jan 24. pii: 5715073. doi: 10.1093.
    PubMed     Abstract available


  450. MAGRO F, Lopes J, Borralho P, Dias CC, et al
    Comparison of the Nancy index with continuous Geboes score: histological remission and response in ulcerative colitis.
    J Crohns Colitis. 2020 Jan 22. pii: 5713474. doi: 10.1093.
    PubMed     Abstract available


  451. MARTIN A, Nachury M, Peyrin-Biroulet L, Bouhnik Y, et al
    Maintenance of remission among patients with inflammatory bowel disease after vedolizumab discontinuation: a multicentre cohort study.
    J Crohns Colitis. 2020 Jan 13. pii: 5701423. doi: 10.1093.
    PubMed     Abstract available


  452. NICOLAIDES S, Vasudevan A, Van Langenberg D
    Medical Management of Infliximab Failure in Acute Severe Ulcerative Colitis.
    J Crohns Colitis. 2020 Jan 13. pii: 5701450. doi: 10.1093.
    PubMed    


  453. AUGER N, Cote-Daigneault J, Bilodeau-Bertrand M, Arbour L, et al
    Inflammatory bowel disease and risk of birth defects in offspring.
    J Crohns Colitis. 2020 Jan 7. pii: 5697329. doi: 10.1093.
    PubMed     Abstract available


  454. LUKAS M, Malickova K, Kolar M, Bortlik M, et al
    Switching from originator adalimumab to the biosimilar SB5 in patients with inflammatory bowel disease: Short-term experience from a single tertiary clinical center.
    J Crohns Colitis. 2020 Jan 6. pii: 5697282. doi: 10.1093.
    PubMed     Abstract available


  455. SCOTT FI, Luo M, Shah Y, Lasch K, et al
    Identification of the most cost effective position of vedolizumab among the available biologic drugs for the treatment of ulcerative colitis.
    J Crohns Colitis. 2020 Jan 4. pii: 5696657. doi: 10.1093.
    PubMed     Abstract available


  456. HOMMEL C, Pillet S, Rahier JF
    Comment on: 'Resolution of CMV Infection in the Bowel on Vedolizumab Therapy'.
    J Crohns Colitis. 2020;14:148-149.
    PubMed    


  457. BIEMANS VBC, van der Meulen-de Jong AE, van der Woude CJ, Lowenberg M, et al
    Ustekinumab for Crohn's Disease: Results of the ICC Registry, a Nationwide Prospective Observational Cohort Study.
    J Crohns Colitis. 2020;14:33-45.
    PubMed     Abstract available


  458. VERDIER J, Breunig IR, Ohse MC, Roubrocks S, et al
    Faecal Micro-RNAs in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2020;14:110-117.
    PubMed     Abstract available


  459. BARNHOORN MC, Wasser MNJM, Roelofs H, Maljaars PWJ, et al
    Long-term Evaluation of Allogeneic Bone Marrow-derived Mesenchymal Stromal Cell Therapy for Crohn's Disease Perianal Fistulas.
    J Crohns Colitis. 2020;14:64-70.
    PubMed     Abstract available


  460. LEVINE A, Chanchlani N, Hussey S, Ziv-Baran T, et al
    Complicated Disease and Response to Initial Therapy Predicts Early Surgery in Paediatric Crohn's Disease: Results From the Porto Group GROWTH Study.
    J Crohns Colitis. 2020;14:71-78.
    PubMed     Abstract available


  461. BRAGA-NETO MB, Gaballa JM, Bamidele AO, Sarmento OF, et al
    Deregulation of Long Intergenic Non-coding RNAs in CD4+ T Cells of Lamina Propria in Crohn's Disease Through Transcriptome Profiling.
    J Crohns Colitis. 2020;14:96-109.
    PubMed     Abstract available


  462. HANAUER SB, Sandborn WJ, Feagan BG, Gasink C, et al
    IM-UNITI: Three-year Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
    J Crohns Colitis. 2020;14:23-32.
    PubMed     Abstract available


  463. TORRES J, Bonovas S, Doherty G, Kucharzik T, et al
    ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment.
    J Crohns Colitis. 2020;14:4-22.
    PubMed    


  464. TRAVIS S
    IM-UNITI at Three Years: Stellar Stelara(R) or Stardust? The Efficacy, Safety, and Immunogenicity of Ustekinumab Treatment of Crohn's Disease.
    J Crohns Colitis. 2020;14:1-3.
    PubMed    


    December 2019
  465. HARRIS RE, Curtis L, Hegde V, Garrick V, et al
    A decade of Varicella screening within a paediatric inflammatory bowel disease population.
    J Crohns Colitis. 2019 Dec 31. pii: 5691246. doi: 10.1093.
    PubMed     Abstract available


  466. FERRANTE M, Sabino J
    Efficacy of anti-JAK inhibitors in ulcerative colitis.
    J Crohns Colitis. 2019 Dec 27. pii: 5687770. doi: 10.1093.
    PubMed     Abstract available


  467. KOBAYASHI T, Uda A, Udagawa E, Hibi T, et al
    Lack of Increased Risk of Lymphoma by Thiopurines or Biologics in Japanese Patients with Inflammatory Bowel Disease: A Large-Scale Administrative Database Analysis.
    J Crohns Colitis. 2019 Dec 23. pii: 5684917. doi: 10.1093.
    PubMed     Abstract available


  468. FLEMING C, Mohan H, Coffey JC
    Should we Resect the Mesentery in Ileocolic Crohn's Disease?-A Response to 'A Warning About the Role of Extended Mesenteric Resection in Crohn's Disease Recurrence'.
    J Crohns Colitis. 2019;13:1584.
    PubMed    


  469. MARK-CHRISTENSEN A, Erichsen R, Veres K, Laurberg S, et al
    Extracolonic cancer risk after total colectomy for inflammatory bowel disease: A population-based cohort study.
    J Crohns Colitis. 2019 Dec 7. pii: 5666210. doi: 10.1093.
    PubMed     Abstract available


  470. CHARILAOU P, Mohapatra S, Joshi T, Devani K, et al
    Opioid Use Disorder Increases 30-Day Readmission Risk in Inflammatory Bowel Disease Hospitalizations: a Nationwide Matched Analysis.
    J Crohns Colitis. 2019 Dec 5. pii: 5658684. doi: 10.1093.
    PubMed     Abstract available


  471. REES WD, Stahl M, Jacobson K, Bressler B, et al
    Enteroids derived from inflammatory bowel disease patients display dysregulated endoplasmic reticulum stress pathways, leading to differential inflammatory responses and dendritic cell maturation.
    J Crohns Colitis. 2019 Dec 4. pii: 5651304. doi: 10.1093.
    PubMed     Abstract available


    November 2019
  472. GISBERT JP, Chaparro M
    Predictors of primary response to biologic treatment (anti-TNF, vedolizumab and ustekinumab) in patients with inflammatory bowel disease: from basic science to clinical practice.
    J Crohns Colitis. 2019 Nov 28. pii: 5645127. doi: 10.1093.
    PubMed     Abstract available


  473. SHARMA U, Olson RK, Erhart FN, Zhang L, et al
    Prescription opioid induce gut dysbiosis and exacerbate colitis in a murine model of Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Nov 27. pii: 5644048. doi: 10.1093.
    PubMed     Abstract available


  474. PAPAMICHAEL K, Cheifetz AS
    Proactive adalimumab monitoring in inflammatory bowel disease: current data and future perspectives.
    J Crohns Colitis. 2019 Nov 25. pii: 5639767. doi: 10.1093.
    PubMed    


  475. KING D, Rees J, Mytton J, Harvey P, et al
    The Outcomes of Emergency Admissions with Ulcerative Colitis between 2007 and 2017 in England.
    J Crohns Colitis. 2019 Nov 12. pii: 5623020. doi: 10.1093.
    PubMed     Abstract available


    October 2019
  476. AKSAN A, Wohlrath M, Iqbal TH, Dignass A, et al
    Inflammation, but Not the Underlying Disease or Its Location, Predicts Oral Iron Absorption Capacity in Patients With Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Oct 28. pii: 5608095. doi: 10.1093.
    PubMed     Abstract available


  477. VAVRICKA SR, Greuter T
    Simple and Simply the Best? Dublin in the European Spotlight.
    J Crohns Colitis. 2019;13:1363-1364.
    PubMed    


  478. PEPPELENBOSCH MP, Parikh K, Fuhler G
    Cannabinoid Signal Transduction Explains Disconnect of Cannabis Effects in Experimental and Clinical Colitis.
    J Crohns Colitis. 2019;13:1479.
    PubMed    


  479. SMEETS FGM, Liedorp PR, van der Poel M, Miclea RL, et al
    Anaplastic Large Cell T Cell Lymphoma in a Patient With Severe Therapy-refractory Crohn's Disease on Long-standing Immunosuppressive Medication During Ustekinumab Treatment: A Case Report and Review of the Literature.
    J Crohns Colitis. 2019;13:1470-1473.
    PubMed     Abstract available


  480. KLAASSEN MAY, Imhann F, Collij V, Fu J, et al
    Anti-inflammatory Gut Microbial Pathways Are Decreased During Crohn's Disease Exacerbations.
    J Crohns Colitis. 2019;13:1439-1449.
    PubMed     Abstract available


  481. MOHAMMADI A, Kelly OB, Smith MI, Kabakchiev B, et al
    Differential miRNA Expression in Ileal and Colonic Tissues Reveals an Altered Immunoregulatory Molecular Profile in Individuals With Crohn's Disease versus Healthy Subjects.
    J Crohns Colitis. 2019;13:1459-1469.
    PubMed     Abstract available


  482. LIEFFERINCKX C, Verstockt B, Gils A, Noman M, et al
    Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study.
    J Crohns Colitis. 2019;13:1401-1409.
    PubMed     Abstract available


  483. NOBLE A, Durant L, Hoyles L, McCartney AL, et al
    Deficient Resident Memory T-Cell and Cd8 T-Cell Response to Commensals in Inflammatory Bowel Disease.
    J Crohns Colitis. 2019 Oct 26. pii: 5607395. doi: 10.1093.
    PubMed     Abstract available


  484. ADLER J
    Can we Improve the Prognostic Value of Phenotype at Inflammatory Bowel Disease Diagnosis?
    J Crohns Colitis. 2019 Oct 22. pii: 5602619. doi: 10.1093.
    PubMed    


  485. CHANDRASINGHE P, Carvello M, Wasmann K, Foppa C, et al
    Transanal ileal pouch-anal anastomosis for ulcerative colitis has comparable long-term functional outcomes to transabdominal approach: a multicentre comparative study.
    J Crohns Colitis. 2019 Oct 22. pii: 5602131. doi: 10.1093.
    PubMed     Abstract available


  486. SCHMITT H, Ulmschneider J, Billmeier U, Vieth M, et al
    The TLR9 agonist cobitolimod induces IL10 producing wound healing macrophages and regulatory T cells in ulcerative colitis.
    J Crohns Colitis. 2019 Oct 20. pii: 5601212. doi: 10.1093.
    PubMed     Abstract available


  487. DE BRUYN M, Ringold R, Martens E, Ferrante M, et al
    The Ulcerative Colitis Response Index for Detection of Mucosal Healing in Patients Treated With Anti-tumour Necrosis Factor.
    J Crohns Colitis. 2019 Oct 19. pii: 5601149. doi: 10.1093.
    PubMed     Abstract available


  488. ELIADOU E, Moleiro J, Ribaldone DG, Astegiano M, et al
    Interstitial and Granulomatous lung disease in inflammatory bowel disease patients.
    J Crohns Colitis. 2019 Oct 11. pii: 5585570. doi: 10.1093.
    PubMed     Abstract available


    September 2019
  489. SMITH RL, Taylor KM, Friedman AB, Gibson RN, et al
    Systematic review: Clinical utility of gastrointestinal ultrasound in the diagnosis, assessment and management of patients with ulcerative colitis.
    J Crohns Colitis. 2019 Sep 28. pii: 5575710. doi: 10.1093.
    PubMed     Abstract available


  490. SCHOEPFER A, Santos J, Fournier N, Schibli S, et al
    Systematic Analysis of the Impact of Diagnostic Delay on Bowel Damage in Paediatric Versus Adult Onset Crohn's Disease.
    J Crohns Colitis. 2019;13:1334-1342.
    PubMed     Abstract available


  491. SINGH K, Al Khoury A, Kurti Z, Gonczi L, et al
    High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
    J Crohns Colitis. 2019;13:1343-1350.
    PubMed     Abstract available


  492. BOLIN K, Hertervig E, Louis E
    The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease.
    J Crohns Colitis. 2019;13:1323-1333.
    PubMed     Abstract available


  493. JERUC J, Drobne D, Zidar N
    Diffuse Colitis Cystica Profunda in Crohn's Disease: A Potential Diagnostic Pitfall.
    J Crohns Colitis. 2019;13:1362.
    PubMed    


  494. FREI R, Fournier N, Zeitz J, Scharl M, et al
    Early Initiation of Anti-TNF is Associated with Favourable Long-term Outcome in Crohn's Disease: 10-Year-Follow-up Data from the Swiss IBD Cohort Study.
    J Crohns Colitis. 2019;13:1292-1301.
    PubMed     Abstract available


  495. PACHLER FR, Toft G, Bisgaard T, Laurberg S, et al
    Use and Success of In Vitro Fertilisation Following Restorative Proctocolectomy and Ileal Pouch-anal Anastomosis. A Nationwide 17-year Cohort Study.
    J Crohns Colitis. 2019;13:1283-1286.
    PubMed     Abstract available


  496. GODNY L, Maharshak N, Reshef L, Goren I, et al
    Fruit Consumption is Associated with Alterations in Microbial Composition and Lower Rates of Pouchitis.
    J Crohns Colitis. 2019;13:1265-1272.
    PubMed     Abstract available


  497. VANDE CASTEELE N, Baert F, Bian S, Dreesen E, et al
    Subcutaneous Absorption Contributes to Observed Interindividual Variability in Adalimumab Serum Concentrations in Crohn's Disease: A Prospective Multicentre Study.
    J Crohns Colitis. 2019;13:1248-1256.
    PubMed     Abstract available


  498. GALAZZO G, Tedjo DI, Wintjens DSJ, Savelkoul PHM, et al
    Faecal Microbiota Dynamics and their Relation to Disease Course in Crohn's Disease.
    J Crohns Colitis. 2019;13:1273-1282.
    PubMed     Abstract available


  499. ADAMINA M, Gerasimidis K, Sigall-Boneh R, Zmora O, et al
    Perioperative dietary therapy in inflammatory bowel disease.
    J Crohns Colitis. 2019 Sep 24. pii: 5573284. doi: 10.1093.
    PubMed     Abstract available


  500. CHAPUY L, Bsat M, Rubio M, Harvey F, et al
    Transcriptomic analysis and High dimensional phenotypic mapping of mononuclear phagocytes in mesenteric lymph nodes reveal differences between ulcerative colitis and Crohn's disease.
    J Crohns Colitis. 2019 Sep 21. pii: 5572419. doi: 10.1093.
    PubMed     Abstract available


  501. RASELLI T, Wyss A, Gonzalez Alvarado MN, Weder B, et al
    The Oxysterol Synthesising Enzyme CH25H Contributes to the Development of Intestinal Fibrosis.
    J Crohns Colitis. 2019;13:1186-1200.
    PubMed     Abstract available


  502. GLICK LR, Sossenheimer PH, Ollech JE, Cohen RD, et al
    Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study.
    J Crohns Colitis. 2019;13:1158-1162.
    PubMed     Abstract available


  503. GONCZI L, Kurti Z, Verdon C, Reinglas J, et al
    Perceived Quality of Care is Associated with Disease Activity, Quality of Life, Work Productivity, and Gender, but not Disease Phenotype: A Prospective Study in a High-volume IBD Centre.
    J Crohns Colitis. 2019;13:1138-1147.
    PubMed     Abstract available


  504. BRIOT C, Faure P, Parmentier AL, Nachury M, et al
    Efficacy, Tolerability, and Safety of Low-Volume Bowel Preparations for Patients with Inflammatory Bowel Diseases: The French Multicentre CLEAN Study.
    J Crohns Colitis. 2019;13:1121-1130.
    PubMed     Abstract available


  505. KHOURY T, Daher S, Massarwa M, Hakimian D, et al
    A Validated Score Assessing the Risk of an Intra-Abdominal Abscess in Patients with Crohn's Disease Presenting at the Emergency Department.
    J Crohns Colitis. 2019;13:1131-1137.
    PubMed     Abstract available


  506. HISAMATSU T, Matsumoto T, Watanabe K, Nakase H, et al
    Concerns and Side Effects of Azathioprine During Adalimumab Induction and Maintenance Therapy for Japanese Patients With Crohn's Disease: A Subanalysis of a Prospective Randomised Clinical Trial [DIAMOND Study].
    J Crohns Colitis. 2019;13:1097-1104.
    PubMed     Abstract available


  507. WEISSHOF R, Ollech JE, El Jurdi K, Yvellez OV, et al
    Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe.
    J Crohns Colitis. 2019;13:1105-1110.
    PubMed     Abstract available


  508. RAWA-GOLEBIEWSKA A, Lenarcik M, Zagorowicz E
    Resolution of CMV Infection in the Bowel on Vedolizumab Therapy.
    J Crohns Colitis. 2019;13:1234-1235.
    PubMed    


  509. ROJO E, Chaparro M, Garcia-Buey L
    Efficacy and Safety of Glecaprevir/pibrentasvir in a Patient With HCV-Induced Porphyria Cutanea Tarda Receiving Vedolizumab for Crohn s Disease.
    J Crohns Colitis. 2019 Sep 17. pii: 5570723. doi: 10.1093.
    PubMed    


    August 2019
  510. LEE C, Hong SN, Paik NY, Kim TJ, et al
    CD1d Modulates Colonic Inflammation in NOD2-/- Mice by Altering the Intestinal Microbial Composition Comprising Acetatifactor muris.
    J Crohns Colitis. 2019;13:1081-1091.
    PubMed     Abstract available


  511. KANSAL S, Catto-Smith AG, Boniface K, Thomas S, et al
    The Microbiome in Paediatric Crohn's Disease-A Longitudinal, Prospective, Single-Centre Study.
    J Crohns Colitis. 2019;13:1044-1054.
    PubMed     Abstract available


  512. BORREN NZ, Luther J, Colizzo FP, Garber JG, et al
    Low-dose Methotrexate has Similar Outcomes to High-dose Methotrexate in Combination with Anti-TNF Therapy in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:990-995.
    PubMed     Abstract available


  513. POTDAR AA, Li D, Haritunians T, VanDussen KL, et al
    Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical Subgroups.
    J Crohns Colitis. 2019;13:1055-1066.
    PubMed     Abstract available


  514. BUISSON A, Mak WY, Andersen MJ, Lei D, et al
    Faecal Calprotectin Is a Very Reliable Tool to Predict and Monitor the Risk of Relapse After Therapeutic De-escalation in Patients With Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:1012-1024.
    PubMed     Abstract available


    July 2019
  515. NEARY PM, Aiello AC, Stocchi L, Shawki S, et al
    High-Risk Ileocolic Anastomoses for Crohn's Disease: When Is Diversion Indicated?
    J Crohns Colitis. 2019;13:856-863.
    PubMed     Abstract available


  516. DEUTSCHMANN C, Sowa M, Murugaiyan J, Roesler U, et al
    Identification of Chitinase-3-Like Protein 1 as a Novel Neutrophil Antigenic Target in Crohn's Disease.
    J Crohns Colitis. 2019;13:894-904.
    PubMed     Abstract available


  517. PEKOW J, Hernandez K, Meckel K, Deng Z, et al
    IBD-associated Colon Cancers Differ in DNA Methylation and Gene Expression Profiles Compared With Sporadic Colon Cancers.
    J Crohns Colitis. 2019;13:884-893.
    PubMed     Abstract available


  518. BISHU S, El Zaatari M, Hayashi A, Hou G, et al
    CD4+ Tissue-resident Memory T Cells Expand and Are a Major Source of Mucosal Tumour Necrosis Factor alpha in Active Crohn's Disease.
    J Crohns Colitis. 2019;13:905-915.
    PubMed     Abstract available


  519. VERSTOCKT B, Dreesen E, Noman M, Outtier A, et al
    Ustekinumab Exposure-outcome Analysis in Crohn's Disease Only in Part Explains Limited Endoscopic Remission Rates.
    J Crohns Colitis. 2019;13:864-872.
    PubMed     Abstract available


  520. VERSTOCKT S, De Hertogh G, Van der Goten J, Verstockt B, et al
    Gene and Mirna Regulatory Networks During Different Stages of Crohn's Disease.
    J Crohns Colitis. 2019;13:916-930.
    PubMed     Abstract available


  521. PIGNEUR B, Lepage P, Mondot S, Schmitz J, et al
    Mucosal Healing and Bacterial Composition in Response to Enteral Nutrition Vs Steroid-based Induction Therapy-A Randomised Prospective Clinical Trial in Children With Crohn's Disease.
    J Crohns Colitis. 2019;13:846-855.
    PubMed     Abstract available


  522. YZET C, Brazier F, Fumery M
    Post-operative Entero-cutaneous Fistula Closure by Over-the-Scope Clip in Crohn's Disease.
    J Crohns Colitis. 2019;13:954-955.
    PubMed    


  523. KEEFER L
    The Time Has Come to Integrate Behavioural Health Services Into IBD Centres.
    J Crohns Colitis. 2019;13:817-818.
    PubMed    


  524. LAMB CA, Mansfield JC, Kirby JA, Keir ME, et al
    The Importance of Molecular Immune Investigation in Therapeutic Clinical Development for Biomarker Assessment.
    J Crohns Colitis. 2019;13:956-957.
    PubMed    


    May 2019
  525. PANACCIONE R, Lofberg R, Rutgeerts P, Sandborn WJ, et al
    Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease Studies.
    J Crohns Colitis. 2019;13:725-734.
    PubMed     Abstract available


  526. BURR NE, Hall B, Hamlin PJ, Selinger CP, et al
    Systematic Review and Network Meta-Analysis of Medical Therapies to Prevent Recurrence of Post-Operative Crohn's Disease.
    J Crohns Colitis. 2019;13:693-701.
    PubMed     Abstract available


  527. BARNHOORN MC, Van Halteren AGS, Van Pel M, Molendijk I, et al
    Lymphoproliferative Disease in the Rectum 4 Years After Local Mesenchymal Stromal Cell Therapy for Refractory Perianal Crohn's Fistulas: A Case Report.
    J Crohns Colitis. 2019;13:807-811.
    PubMed     Abstract available


    April 2019
  528. MAO R, Chen YJ, Chen BL, Xie XH, et al
    Intra-Cavitary Contrast-Enhanced Ultrasound: A Novel Radiation-Free Method for Detecting Abscess-Associated Penetrating Disease in Crohn's Disease.
    J Crohns Colitis. 2019;13:593-599.
    PubMed     Abstract available


  529. CHAVANNES M, Martinez-Vinson C, Hart L, Kaniki N, et al
    Management of Paediatric Patients With Medically Refractory Crohn's Disease Using Ustekinumab: A Multi-Centred Cohort Study.
    J Crohns Colitis. 2019;13:578-584.
    PubMed     Abstract available


  530. OSTROWSKI J, Dabrowska M, Lazowska I, Paziewska A, et al
    Redefining the Practical Utility of Blood Transcriptome Biomarkers in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2019;13:626-633.
    PubMed     Abstract available


  531. RIPOLLES T, Martinez-Perez MJ, Paredes JM, Vizuete J, et al
    The Role of Intravenous Contrast Agent in the Sonographic Assessment of Crohn's Disease Activity: Is Contrast Agent Injection Necessary?
    J Crohns Colitis. 2019;13:585-592.
    PubMed     Abstract available


  532. CORRALIZA AM, Ricart E, Lopez-Garcia A, Carme Masamunt M, et al
    Differences in Peripheral and Tissue Immune Cell Populations Following Haematopoietic Stem Cell Transplantation in Crohn's Disease Patients.
    J Crohns Colitis. 2019;13:634-647.
    PubMed     Abstract available


  533. KAKUTA Y, Kawai Y, Naito T, Hirano A, et al
    A Genome-wide Association Study Identifying RAP1A as a Novel Susceptibility Gene for Crohn's Disease in Japanese Individuals.
    J Crohns Colitis. 2019;13:648-658.
    PubMed     Abstract available


  534. HAIN E, Maggiori L, Orville M, Treton X, et al
    Diverting Stoma for Refractory Ano-perineal Crohn's Disease: Is It Really Useful in the Anti-TNF Era? A Multivariate Analysis in 74 Consecutive Patients.
    J Crohns Colitis. 2019;13:572-577.
    PubMed     Abstract available


  535. HEDIN CRH, Vavricka SR, Stagg AJ, Schoepfer A, et al
    The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy.
    J Crohns Colitis. 2019;13:541-554.
    PubMed     Abstract available


  536. ROOSENBOOM B, van Lochem EG, Horjus Talabur Horje CS
    AlphaE Expression in Inflammatory Bowel Disease: a Biomarker for the use of Etrolizumab?
    J Crohns Colitis. 2019;13:671.
    PubMed    


    March 2019
  537. D'HOORE A
    Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease: Immediate Surgical Implications!
    J Crohns Colitis. 2019;13:271-272.
    PubMed    


  538. DE GROOF EJ, van der Meer JHM, Tanis PJ, de Bruyn JR, et al
    Persistent Mesorectal Inflammatory Activity is Associated With Complications After Proctectomy in Crohn's Disease.
    J Crohns Colitis. 2019;13:285-293.
    PubMed     Abstract available


    February 2019
  539. MAASER C
    New ECCO Guidelines Generation.
    J Crohns Colitis. 2019;13:141.
    PubMed    


  540. SZVARCA D, Borum ML
    Don't Be Late on Latent TB: Inconsistent Tuberculosis Screening in IBD Patients on Biologics.
    J Crohns Colitis. 2019;13:270.
    PubMed    


    January 2019
  541. WIERINGA JW, van der Woude CJ
    Editorial: The Effect of Thiopurines on Offspring.
    J Crohns Colitis. 2019;13:1-2.
    PubMed    


  542. SZVARCA D, Greenfest A, Borum M
    WebIBD: How Much Can We Trust Medical Information Online?
    J Crohns Colitis. 2019;13:138.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: